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ABSTRACT 
THE TREATMENT OF PERIPHERAL NERVE INJURIES 
WITH CYROPRESERVED AUTOGRAFTS. 
A FUNCTIONAL, HISTOLOGICAL, AND 
BIOCHEMICAL EVALUATION OF THE ROLE 
OF CRYOPRES ERVATION IN THE RAT MODEL. 
PATRICK ALAN RUWE 
1987 
Adult male Sprague-Dawley rats were used as a 
model to study the treatment of peripheral nerve 
injuries with cryopreserved autografts. Three 
experimental groups were used. The first control 
grafted group (n=ll) recieved a 2.0 cm fresh 
autograft. The second cryopreserved group (n=12) 
recieved a 2.0 cm cryopreserved graft. The third gap 
nongrafted group (n=13) was left with a 2.0 cm deficit 
in one sciatic nerve. Histological, functional, and 
biochemical evaluations of the role of 
cryopreservation were undertaken. 
Results showed a mean fiber density of myelinated 
axons in the fresh autograft group of 5,025 (SD,457) 
and in the cryopreserved autograft group of 5,126 
(S D,297). The normal mean value for this segment of 
nerve was 3,885 (SD,744). In functional tests the 
fresh grafted animals had a mean flexion contracture 
of 18° compared to 14° in the cryopreserved 
animals. The gap control animals had a mean flexion 
contracture of 49°. The mean weight for a tibialis 
anterior (TA) muscle innervated by a fresh nerve graft 
was .5877 grams (SD,.0746) and innervated by a 
cryopreserved nerve graft .5801 grams (SD,.0935). The 
mean weight of a TA muscle in the gap control group 
was .2089 grams (SD,.0844). The mean hydroxyproline 
(HP) percentage in TA muscle innervated by a fresh 
graft expressed as op/control leg was 1.527 and 
innervated by a cryopreserved graft 1.660. The mean 
HP ratio in gap control animals was 4.315. 
Our results have shown that fresh and 
cryopreserved autografts are not statistically 
different in their ability to potentiate regeneration 
of axons and return of function in the rat. They are 
however, superior in this ability to gap control 
animals. These findings have immediate clinical 
applicability in cases of segmental nerve loss in a 
wound not immediately ready for grafting or in a 
patient not yet stabilized for major sugery. 
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Ruwe 1 
I. Introduction 
Physicians have long dreamed of one day having the 
ability to replace worn, diseased or damaged human body 
parts with donor tissue. Medical researchers have made 
great advances in the field of organ transplantation with 
respect to kidney, heart, liver, bone, and corneal 
transplantation. Unfortunately, the successful 
transplantation of nervous tissue and specifically 
peripheral nerves has lagged far behind the rest. 
The repair of large defects in peripheral nerves after 
traumatic injury is a frequent and frustrating problem in 
surgery of the extremities. Often, as the result of an 
accident, a patient is left with an anatomically intact 
distal extremity without adequate motor or sensory 
innervation to allow satisfactory function. 
Currently, peripheral nerve injuries are treated using 
autografts such as the sural nerve which are harvested from 
the patient at the time of reconstructive nerve surgery 
[16,19]. Several problems make this approach to the 
treatment of peripheral nerve injuries less than optimal. 
Unlike other autografts such as vein and bone grafts, the 
removal of nerve to obtain tissue for autogenous nerve 
grafting leaves a permanent neurologic deficit. 
Furthermore, the amount of donor tissue is inherently 
limited. If it were possible to use cadaveric allografts, 
the aforementioned problems would be averted. 
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Two major difficulties must be overcome for the 
allogeneic nerve tissue approach to be effective. Firstly, 
immunosuppression may be required. Secondly, optimal 
methods for storing or banking nerve tissue must be 
determined. A great deal of work has and continues to be 
directed toward the question of immunosuppression. 
Zalewski et al. [119,120] have demonstrated that allogeneic 
nerve tissue is antigenic and that the immune response in 
the recipient animal can be altered by cyclosporin-A. In 
addition, several investigators have tested various methods 
for decreasing the antigenicity of the nerve tissue itself 
[36,59,60,61,64,81,97,100,118]. It is the purpose of this 
thesis to study the latter question concerning optimal 
methodology for storing or banking nerve tissue without 
which allogeneic nerve grafting would be much less 
practical. Specifically, this paper will address the 
treatment of peripheral nerve injuries with cryopreserved 
autografts evaluating the role of cry©preservation in the 
rat model. A comparison will be drawn between fresh and 
cryopreserved autografts and interpreted with respect to 
functional tests, sensory tests, axonal counts, and 
hydroxyproline assays. The use of autografts has been 
chosen in a specific attempt to minimize the role of the 
immune response in this model [125]. 
The clinical need for a system for banking peripheral 
nerve is obvious. As previously stated, allogeneic nerve 
grafts harvested from cadaveric donors would require 
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cyropreservation to be practical. But cryopreservation and 
peripheral nerve banking also has an immediate and proven 
clinical application with respect to autogenous tissue. 
The ability to bank autogenous nerve tissue would be 
invaluable in the care of the major trauma patient with 
multiple limb injuries. Viable nerve tissue could be 
harvested in an unsalvagable or amputated limb and stored 
for delayed repair of segmental nerve loss in a wound not 
immediately ready for grafting or in a patient not yet 
stabilized for major surgery. In addition, proven 
cryopreservation technique would afford the surgeon the 
option to perform reconstruction in an elective rather than 
emergent setting and thus avoid many of the problems 
associated with emergency surgery. 
It is the authors' hope that this work will take a 
small step toward establishing the role of cryopreservation 
in peripheral nerve grafting and in so doing potentiate a 
larger step toward the dream of using allogeneic tissue to 
repair peripheral nerve defects in man. 
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II. Review of the Literature 
A. Historical Perspective of Nerve Grafting 
Physicians have been experimenting with nerve 
grafting, allografting, autografting, and xenografting for 
over one hundred years. Peripheral nerve allografting 
started experimentally in 1870 with the now classic work of 
Philipeaux and Vulpian reported in the French literature 
[78]. They reported results showing that a graft could 
conduct nerve fibers across a defect. Other early authors 
were able to duplicate their results showing that grafted 
pieces of nerve could be used to conduct nerve fibers 
across peripheral nerve lesions [7,17,41]. The first 
clinically reported allograft in man was reported by Albert 
[3] in 1878 in the German literature. He described a 
procedure by which he transplanted an allograft nerve 
segment from an amputated limb to bridge a 3.0 cm deficit 
of the median nerve in the recipient's forearm created as 
the result of the resection of a sarcoma. This patient, 
however, never recovered function in the limb. The first 
reported clinical allografting in the English literature 
appeared in 1889 in the form of a paper read before the 
Clinical Society of London by Mayo-Robson [66]. He 
described the case of a fourteen year old girl who was left 
with a two inch deficit in her median nerve as the result 
of tumor surgery with resultant loss of function in her 
affected hand. Repair of the median nerve was effected by 
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grafting a 2 1/2 inch segment of the posterior tibial nerve 
harvested from the freshly amputated leg of another 
patient. One might question Mayo-Robson's results as he 
goes further to describe return of sensation within 
thirty-six hours and gradual return of function in the 
paralyzed muscles [66]. Perhaps encouraged by his earlier 
reported successes, Mayo-Robson in 1890, used the. sciatic 
nerve of a rabbit to bridge a gap in the ulnar nerve of a 
gardener who had lacerated his forearm with a scythe. 
Faced with a 2 1/2 inch deficit in the median nerve of the 
same patient and having previously exhausted his supply of 
rabbit sciatic nerve he dissected free and interposed a 
segment of the rabbit's spinal cord into the gap. 
Mayo-Robson further described complete functional recovery 
in this patient after several years. 
Unfortunately, Mayo-Robson's successes have not been 
verified in the laboratory. Huber [41], in 1895, reported 
early success in grafting the sciatic nerves of cats into 
dogs but twenty years later as the result of more extensive 
and controlled work concluded that xenografts were less 
successful than autografts or allografts. Eden [31], in 
1919, and Cajal [17], in 1928, condemned the use of 
xenographs as a result of their own separate investigations 
and with respect to careful review of the current 
literature of the day. 
Concurrent with the condemnation of heterografts many 
authors were finding experimentally reproducible success as 
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judged by recovery of sensation and motor function with 
autografts in both animals and man [10,17,30,31,35,43]. 
Foerster [35] reporting in the German literature in 
1929 described his series of twenty-one autografts. Of 
these cases, five patients experienced complete recovery of 
both sensory and motor function. Another twelve patients 
experienced partial return while only two cases were judged 
as failures and two cases were lost to follow-up. Nerve 
autografting, however, did not gain universal popularity 
and approval until the work of Ballance and Duel [7] was 
published in 1932 in the Archives of Otolaryngology. They 
reported on the success of the operative treatment of 
facial palsy by the use of autografts to repair the facial 
nerve. Concomitantly with Ballance and Duel's work, Bunnel 
and Boyes [15] described the successful use of autografts 
to repair digital nerve defects in their series of 
thirty-two patients. 
Through the work of these and other investigators the 
efficacy of autografting was established almost fifty years 
ago. Unfortunately, as previously mentioned the use of 
autografts is inherently limited by the supply of tissue 
and by the creation of permanent neurologic deficits at the 
donor site. These factors are magnified in the case of a 
lesion involving a long segment of nerve or a large 
diameter axon and limit the clinical application of 
autografts in humans. 
The use of allografts in the repair of peripheral nerve 
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lesions would appear as the ideal solution. A large defect 
in the median nerve could be repaired with an anatomically 
similar segment from the median nerve of a cadaveric donor 
without the recipient incurring further neurologic loss. 
Some early authors reported initial success with 
allografts in the animal laboratory [31,43,49]. However, 
their transplantation technique, experimental methodology, 
and interpretation of results were inconsistent and not 
fully described. In 1918, Verga [108] was among the first 
to demonstrate through histology that an allograft could at 
first unite with the host tissue but later degenerate. 
Eden [31] confirmed these results a year later showing 
again histologically that axons from the proximal host 
stump could grow a short distance into the allograft but 
more distally would be replaced by fibrous scar tissue. In 
his experimental model, Eden attempted a 5.0 cm allograft 
in the sciatic nerve of a dog. Histological examination 
revealed sparse axonal regeneration in the proximal graft 
while the remainder of the graft was largely replaced by 
fibrous tissue. As the result of independent research, 
Stookey [102] and Huber [43] concluded that this dense 
fibrous tissue which formed in response to the allograft 
acted as a mechanical barrier to the regeneration of the 
nerve axon down the allograft. 
In an attempt to standardize the assessment of the 
efficacy of the various types of grafting procedures in 
light of the often contradictory findings in the literature 

Ruwe 8 
of the day and to address the issue of fibrous replacement 
of grafted nerve segments, Sanders and Young [90], in 1942, 
compared the results of nerve grafting with fresh and 
predegenerated autografts, fresh and pretreated allografts, 
and fresh and pretreated xenografts. They, along with 
Guttman and Sanders [39], took the various types of nerve 
grafts and inserted them into the peroneal nerve of the 
rabbit. Dog and rat nerve segments were tested in 
xenograft experiments. After fifteen to twenty-five days 
and sometimes longer, examination was made of the 
histological changes in the graft and the distance of 
outgrowth of host axons. The authors concluded that the 
cells of the allograft were destroyed as a result of a host 
immune reaction, the severity and time of commencement of 
which was determined by the genetic relationship of the 
host and the donor and the amount of tissue transplanted. 
These immune reactions were even more pronounced in the 
xenografted animals. They further demonstrated that the 
Schwann cells of an autograft survive and multiply setting 
up a channel for sprouting axons thus effecting a good 
basis for recovery. 
Around the time of Saunders and Young's classic work 
two clinical allograft series appeared in the literature. 
Seddon and Holmes [93], in 1944, unsuccessfully attempted 
four human allografts which upon subsequent exploration 
revealed total replacement by fibrous tissue. In 1945, 
Spurling et al. [99] reported the results of their series 
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of eight cases of human allografts all of which on 
re-exploration revealed replacement by fibrous tissue. 
This basic problem of inflammatory response and fibrous 
replacement of allograft tissue first described by Saunders 
and Young and now known to be the result of the 
immunological rejection of foreign proteins by the host, 
renders any type of peripheral nerve allograft procedure 
impractical unless an alteration in immune response can be 
found. It is in this direction that the current scope of 
peripheral nerve allograft research is directed. The 
results of Sanders and Young's attempts to alter the immune 
response in their classic article by predegeneration, 
formol fixation or alcohol saturation were equivocal. But 
clearly, they set the tack for future investigations. 
B. Contemporary Progress in Peripheral Nerve 
Allografting 
Since the early work of Sanders and Young elucidating 
the immune reaction to peripheral nerve allografts, 
research has been directed first toward decreasing the 
antigenicity of the nerve graft itself without altering its 
physiological properties and later, with the advent of 
immunosuppressive pharmacological agents and a greater 
understanding of the immune system, toward alteration of 
the host response. 
Early attempts at altering the immunogenecity of 
allograft segments met with limited success. Cajal [17], 
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in 1928, was among the first to propose predegeneration of 
nerve graft segments on purely theoretical grounds. In 
1933, Duel [30] published the results of his work in the 
laboratory with predegenerated autografts. Huber [43] 
attempted, in 1920, to store nerve tissue in vaseline with 
limited success. Cajal [17] concluded that grafts treated 
by boiling water, chloroform, formalin, and chloral hydrate 
were not innervated and that dead grafts had limited 
clinical application. 
In the past twenty years, a select number of 
investigators have contributed markedly to the field of 
peripheral nerve allograft research. Stimulated by 
previous clinical success with cathode-irradiated 
allogeneic bone grafts and from information gained as the 
result of previous studies of successful cathode-irradiated 
allogeneic tendon grafts in chickens, Leonard Marmor [64], 
in 1964, pioneered the use of electron radiation to reduce 
the foreign body reaction well described in the literature 
in response to allogeneic nerve grafts. Campbell and 
Bassett [126] had, in 1959, described the use of 
irradiation in peripheral nerve grafts, but had done so in 
combination with the use of a millipore tube, a 
cellulose-acetate filter which acts as a cell barricade 
while allowing the defusion of tissue fluids to the nerve 
grafts. They, however, attributed their successful 
reduction of the immune response to the millipore filter. 
Reporting at the 1962 meeting of the American Academy of 
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Orthopaedic Surgeons, Marmor described his implantation of 
irradiated allogeneic nerve segments in one thigh and 
non-irradiated allogeneic nerve segments in the opposite 
thigh of two isogeneic strains of rats which differed with 
respect to both minor and major transplantation antigens. 
Two weeks after implantation, the irradiated nerve graft 
was intact with no evidence of local immune reaction. By 
contrast the non-irradiated graft had been invaded by 
inflammatory cells resulting in marked fibrosis and 
destruction of the graft. Similar results were seen at six 
weeks. Marmor concluded that irradiation drastically 
reduced the foreign body rejection phenomena and set up an 
experiment to determine whether long nerve defects could be 
bridged successfully with irradiated allografts employed in 
a physiological manner. 
In his series of three mongrel dogs, Marmor repaired a 
3.0 cm deficit in the peroneal nerve with a 3.5 cm 
irradiated allograft. Three weeks after the operation, 
electromyograms revealed complete denervation of the dogs' 
dorsiflexor muscles of the foot and physical exam revealed 
a foot drop and a limited gait in each of the animals. At 
six months, Marmor reported normal EMGS, resolution of foot 
drop, and normal gait with no evidence of weakness in all 
three dogs. Histological exam revealed regenerated axons 
in and distal to the graft with minimal fibrous tissue 
proliferation [64]. Marmor's experimental findings could 
have been strengthened by the use of more animals and by 
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the use of a group which received non-irradiated grafts and 
a group which received no graft at all as a check for 
spontaneous regeneraton. In addition, the choice of 
mongrel dogs caused the animals' antigeneic disparity to be 
unknown. 
In his book entitled Peripheral Nerve Regeneration 
Using Nerve Grafts published in 1967 [125], Marmor reported 
his clinical results using irradiated allografts to repair 
peripheral nerve defects in twenty-five humans from 1961 to 
1966. The grafts which Marmor inserted ranged in length 
from 4.5 to 22.0 cm. Some patients recovered sensation and 
two experienced some subjective return in motor function, 
but the great majority of grafts were unsuccessful. In his 
book Marmor concludes that successful allografts would 
require further protection against destruction in addition 
to irradiation and proposed the use of suppression of the 
host response by systemic drugs. 
In later work, Marmor et al. [65] describe an 
experiment in rats designed to study the effect of nontoxic 
doses of the immunosuppressive drug Imuran on 
homotransplantation of peripheral nerves, both alone and in 
combination with graft irradiation. Repeating 
nonphysiological techniques used in previous experiments 
[64], the authors concluded as a result of histological 
findings that the immune rejection response to nerve 
allografts can be prevented in animals by the 
administration of Imuran in nontoxic doses [65]. As in 
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earlier experiments, the authors chose to use a very 
limited number of animals (in this case a total of ten with 
two animals sacrificed at five one-week intervals). In 
addition, unlike in their previous study, the authors used 
Sprague-Dawley rats, an outbred strain with an unknown 
histocompatibility complex, for their model and again 
failed to report data from a control group which would 
receive untreated nerves and no immunosuppression. 
Nevertheless, Marmor's work represents the first attempt to 
combine a technique to decrease the antigenecity of the 
allograft nerve segment with systemic immunosuppression of 
the host. 
Ducker and Hayes [29], in 1970, reported their results 
from attempts to decrease the allograft antigenecity. They 
attempted to duplicate Marmor's work with irradiation while 
also testing the effect of Wallerian degeneration on the 
immune response. No attempt was made to alter the host 
immune reaction with systemic immunosuppressive drugs. 
They avoided the problems Marmor had with experimental 
design by replacing a 2.0 cm nerve segment in dogs with 1) 
a control measured gap with nerve ends sutured to fascia, 
2) an autograft nerve segment, 3) a predegenerated 
allograft (three weeks), and 4) an irradiated allograft. 
Each experiment was done using grafts of two different 
lengths (2.0 cm, 4.0 cm). Measurements of threshold 
stimuli and conduction times across the graft were used to 
judge results at six months. No attempt at functional 
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evaluation was undertaken. The results showed unsuccessful 
reinnervation in both the gap and predegenerated grafts. 
The 2.0 cm autografts and irradiated allografts were highly 
successful. The 4.0 cm irradiated graft was marginally 
successful. By histological analysis, the authors showed 
that in the predegenerated grafts, an inflammatory response 
created thick scar tissue and blocked axons from growing 
into the graft. In earlier studies involving chimpanzees 
receiving allografts of varying lengths (2.0 - 7.0 cm) 
which had been both predegenerated and irradiated, they 
found 80 percent success in grafts under 4.5 cm in length 
while only 33 percent success in longer grafts [29]. It 
should be noted again that no functional studies were 
performed. From their data the authors concluded that the 
best nerve graft was an autograft of less than 4.0 cm in 
length (90 percent effective). The maximum length 
practical for allografts treated by irradiation and 
degeneration in higher primates was also 4.0 cm (80 percent 
effective) [29], 
Buch [13] in an attempt to duplicate the earlier 
results of Marmor [64,65] studied the effect of 
pretreatment with irradiation in guinea pigs and dogs. He 
concluded that prior radiation exposure of nerve allografts 
minimizes but does not totally obviate the inflammatory 
response or subseguent fibrosis. 
In order to explore the exact mechanism for the now 
established beneficial effect of exposing frozen nerve 
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segments to extremely high levels of radiation 
[13,29,64,65] Verhoog and van Bekkum [109] devised an 
experimental model consisting of heterotopic 
transplantation of peripheral nerve segments under the 
kidney capsule of rats. They graded their results by 
counting the infiltrated round cells in stained 
histological sections of the graft. As a result of low 
dose radiation (1500, 15,000 rads) they found little 
inhibition of the lymphocytic response, but complete 
absence of this response in grafts receiving high dose 
radiation (150,000 rads). Similar results were seen with 
exposure to increasing concentrations of the cytotoxic 
agent Cialit. They further showed that freezing to -192° 
C without the cyroprotectant agent DMSO also inhibited the 
immune response while cryoprotection restores the tendency 
for lymphocytic infiltration. They concluded that 
transplantation antigens responsible for the allograft 
response are expressed only by living cells, and 
therefore, cell death was the responsible mechanism for 
inhibition of immune response secondary to irradiation 
[109]. 
J.D. Pollard [80,83] and his associates working in 
Australia reported in 1973 results from their work with 
respect to ultrastructural comparisons and classification 
of general host response to peripheral nerve allografts and 
autografts. They further performed a physiological study 
involving their attempt to limit the immune response in 
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peripheral nerve allografts by means of Imuran therapy. 
With regard to the host response, Pollard characterized the 
allograft response on the cellular level as an invasion of 
graft tissue by lymphocytes, plasma cells, and activated 
macrophages which disrupt the normal nerve architecture 
causing rupture and subseguent compression of neurolemmal 
tubes, thus, effectively blocking the conduit for axonal 
sprouting [80]. He describes this progressive obliteration 
as beginning three weeks after grafting and leading to 
large areas of collapsed neurolemmal tubes embedded in 
collagen by four months. He further classifies three major 
distinguishing features between autografts and allografts. 
Firstly, the lymphocyte and plamsa cell infiltration is 
completely absent in the autograft. Secondly, the dominant 
cell within the neurolemmal tube in the autograft was the 
Schwann cell whereas in the allograft it was the 
macrophage. In fact, there was no evidence of Schwann cell 
survival at all in the allograft. Thirdly, whereas the 
neurolemmal tube was shown to survive for long periods of 
time and to conduct a column of Schwann cells and 
regenerating axons to the periphery in autografts in the 
allograft the majority of neurolemmal tubes were as 
previously mentioned collapsed and compressed by 
surrounding collagen. Pollard proposes that successful 
results in peripheral nerve allografts are dependent on 
immune suppression of this destruction of neurolemmal tubes 
[80]. 
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To test his theory, Pollard set up an experimental 
allograft model utilizing forty-two Wistar rats. 
Unfortunately, he failed to identify the strain of rat 
which served as the nerve donor so we have no information 
regarding histocompatibility differences. One half of the 
rats received Imuran in nontoxic doses during the 
regeneration period. Results were judged to be 
significantly better in the Imuran treated group at six 
months with respect to motor conduction velocity and 
density of myelinated fibers within and distal to the graft 
[83]. The authors concluded that treatment with Imuran 
lessens the intensity of the immune response responsible 
for rupture and collapse of neurolemmal tubes [80] allowing 
the regeneration through nerve allografts to occur more 
readily [83] in the treated group. 
In an attempt to identify the constituents of 
peripheral nerve allografts which evoke an immune response 
Pollard and McLeod [81] investigated the fate of donor 
Schwann cells by inserting nerve grafts into trembler mice 
which have a hereditary demyelinating neuropathy allowing 
easy distinction between host and donor Schwann cells. By 
using predegenerated grafts devoid of myelin, the authors 
proposed by electrophysiological and histological criteria 
that when significant histocompatibility differences 
existed, Schwann cells within nerve allografts were 
rejected irrespective of the presence or absence of myelin 
within the nerve graft. The authors concluded that Schwann 

Ruwe 18 
cells, not myelin, constitute the principal antigen within 
nerve autografts and that their rejection is responsible 
for neurolemmal tube collapse, thus, limiting the success 
of nerve allografts. It is difficult to draw conclusions 
by the above data and without description of statistical 
analysis. One cannot conclude by showing in a 
multidimensional model, in this case a peripheral nerve 
allograft, that grafts were rejected whether or not they 
contain myelin that donor Schwann cells are responsible for 
this immune response. Evidence could be gained by 
selectively killing allogeneic Schwann cells before 
grafting and showing resultant inhibition of the immune 
response. Clearly, more work is needed in this area. 
Levinthal [53] reporting results from a comparative 
experiment orthotopically transplanted nerve fascicles 
between different strains of antigenetically identified 
rats [74]. He could not differentiate an allografted 
fascicle from its autografted control as judged with 
respect to cellular reaction, macrophage response, 
connective tissue proliferation, distal myelination or 
estimated axonal ratios. Levinthal et al. concluded that 
the major transplantation antigens responsible for the 
immune response are predominantly expressed in the 
epineural and surrounding connective tissues, while 
fascicular or perineural elements of the grafts are less 
antigenic [53]. 
In an attempt to show that histocompatibility plays a 
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major role in the results of peripheral nerve surgery, 
Bucko and Steinmuller [14] , reported in 1974 their results 
using 3.0 cm isografts, allografts, and xenografts in 
highly inbred rats. They found reinnervation of denervated 
rat tails in ten of eleven trials with isografts, two 
reinnervations in fifty-nine rats receiving allografts 
pretreated by irradiation, freezing, lyophilization, 
predegeneration, or a combination of the above, and total 
failure in all cases of fresh allografts or xenografts. By 
using statistically significant numbers of animals and 
strict experimental design, they concluded that although 
the possibility of unknown non-immunogenic factors existed, 
transplantation immunity played the major role in 
preventing regeneration in the allogeneic model [14]. 
With the role of histoincompatibility in the prevention 
of regeneration in peripheral nerve allografts gaining 
acceptance in the literature, Singh, Melchese, and Stefanko 
[94,95] reporting from the Netherlands were among the first 
to investigate the influence of tissue typing on nerve 
regeneration. From their study involving thirty-six dogs 
tissue typed with respect to the major histocompatibility 
complex system and broken down into three major groups 
(group 1 receiving a 4.0 cm graft; group 2, a 4.0 cm graft 
subjected to radiation; and group 3, a 7.0 cm graft), they 
concluded that compatible tissue typed nerve allografts 
behave more like autografts and are, therefore, more 
readily accepted by the host tissue. Unfortunately, their 

Ruwe 20 
experimental model was fraught with problems. Firstly, the 
authors failed to describe the exact histocompatibility 
differences between the dogs used for allografting as 
determined by tissue typing. Secondly, they subjected all 
nerve grafts to freezing to -70° C for four to six weeks 
without a cryoprotectant agent prior to implantation. 
Verhog and von Bekkum [109] had shown earlier that freezing 
without a cryoprotectant agent inhibited the immune 
response by killing the cells which carry the 
transplantation antigens. Furthermore, Singh et al. had 
no control group to present data as to whether fresh nerve 
allografts were rejected. This would help to clarify the 
dogs' antigenic differences and to help elucidate the role 
of cryopreservation. Thirdly, the authors failed to 
describe the level of radiation used in their experiments. 
Marmor [64] had in earlier work shown that low dose 
radiation had a limited effect on the immune response while 
high dose radiation suppressed the response by killing the 
cells. Singh et al. had presumably already killed the 
cells by freezing them without a cryoprotectant agent 
[109]. In the interpretation of their results Singth et 
al. [94,95] used the maximum nerve conduction velocity and 
a subjective interpretation of histological findings as the 
criteria for judging their results. Even with such 
criteria their results were not statistically significant 
when they compared compatible and noncompatible 4.0 cm 
grafts without radiation treatment. 
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In a later project, Singh et al. [97] studied the 
histocompatibility requirements for successful frozen nerve 
allografts in forty-six dogs. In this project they avoided 
some of their earlier experimental design problems by 
describing exactly the number of sites on the major 
histocompatibility complex in which each dog differed. 
Further, they described the exact dose of radiation used in 
the pretreatment of the graft. Again, however, they 
cryopreserved all grafts without a cryoprotectant agent and 
failed to present data involving fresh nerve allografts as 
controls. Using their previously described criteria 
[94,95] to judge the results Singh et al. [97] concluded 
that minor histocompatibility differences did not lead to 
rejection of the frozen nerve allografts even in grafts of 
7.0 cm length. In fact, Singh et al. reported that five 
out of six dogs receiving 7.0 cm allografts recovered 
completely normal conduction velocities. In previously 
reported more controlled studies, Ducker and Hayes [29] had 
shown that even in 4.0 cm autografts in dogs conduction 
times in the best results were decreased by 15 percent. 
Furthermore, Ducker and Hayes found vascular insufficiency 
to be a limiting factor in autografts over 4.0 cm. 
Clearly, Singh et al. findings would be dramatic if their 
results could be reproduced under more controlled 
conditions. 
In a direct attempt to provide confirmation that host 
axons can regenerate through a long nerve allograft 
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provided that the allograft bears only minor 
transplantation antigens and is frozen and thawed before 
transplantation, Zalewski and Gulati [118] working at the 
National Institute of Health reported, in 1982, the results 
of their research using the rat model. In their model, 
host isogeneic Fisher rats received a 4.0 cm fresh or 
frozen allograft from isogeneic Lewis rats. Fisher and 
Lewis rats are known to differ only with respect to minor 
transplantation antigens [74]. Grafts were frozen in 
exactly the same manner as in Singh et al.'s [97] 
experiment without the use of a cryoprotectant agent. 
Histological examination showed that at two and nine months 
only the fresh isograft permitted host axon regeneration. 
Only a few axons regenerated into the most proximal portion 
of either the frozen isografts or the fresh allograft. 
Histological examination of separate specimens after two 
weeks revealed that freezing killed most of the Schwann 
cells [118] as had been reported earlier [29]. The authors 
concluded that axonal regeneration through a long frozen 
nerve graft fails in rats because freezing destroys Schwann 
cells [118]. Clearly Zalewski and Gulati's findings failed 
to confirm Singh et al.'s work in dogs. 
In further work, Zalewski and Silvers [129] avoiding 
the unclear role of cryopreservation investigated whether a 
fresh nerve allograft containing only minor transplantation 
antigens would be superior to one containing minor and 
major incompatibilities in both normal and immunologically 
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tolerant rats [121]. The author's experimental model 
involved the grafting of the peroneal nerve in rats. 
Success of the nerve graft was evaluated by determining 
whether host motor nerve fibers grew through the nerve 
graft to reinnervate the tibialis anterior (TA) and 
extensor digitorum longus (EDL) muscles. Rats were checked 
clinically for foot drop as well as for evidence of 
muscular atrophy [121]. They found that nerve fibers were 
able to regenerate functionally through 2.0 cm and 4.0 cm 
isografts and through 2.0 cm allografts containing minor or 
minor and major histocompatibility differences. The 4.0 cm 
allografts failed irrespective of histocompatibility. The 
2.0 and 4.0 cm allografts were, however, successful when 
transplanted into immunologically tolerant rats. Zalewski 
and Silvers classified histologically successful grafts as 
having sometimes greater or sometimes less axons than the 
proximal stump, but always having axons of thinner diameter 
[121]. The authors conclude that even minor antigens can 
evoke an immune response sufficient to prevent functional 
regeneration through a long length of nerve allograft. 
From the results of the immunologically tolerant group, 
they concluded that host immunosuppression offers the best 
hope of achieving regeneration through a long nerve 
allograft [121]. Again, Zalewski's work contradicts Singh 
et al.'s conclusions [97]. Unfortunately, there were 
problems with Zalewski and Silver's experimental design. 
To achieve a 4.0 cm graft, the authors combined two-2.0 cm 
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graft segments, thus, requiring regenerating axons to cross 
three suture lines rather than two. deMedinaceli 
[24,25,26], and others [94,95] have shown that the 
resultant blood clot and cellular debris at a suture line 
can be a critical factor in determining whether axons can 
regenerate across lines of union. The authors failed to 
report any histological findings with respect to the suture 
lines. In addition, with respect to allografts involving 
immunologically tolerant rats, results were reported only 
in animals who differed with respect to minor 
histocompatability antigens. Since the controversy as to 
the role of minor HLA differences in graft rejection was, 
in fact, the focus of their work, conclusions could have 
been stronger if additional data had been reported. 
Specifically data, with respect to allografts, between 
immunologically tolerant animals which differed with 
respect to major antigens was needed. 
Clearly, controversy exists in the literature with 
respect to the role of minor transplantation differences in 
the rejection process of peripheral nerve allografts 
[97,121]. To shed light on the issue, Mackinnon et al. 
[57] investigated the nerve allograft response between 
closely and distantly related inbred strains of rats using 
both histology and the 51Cr release cytotoxicity assay to 
pr -i 
assess antigen recognition. Briefly, the Cr assay is 
used to assess the cytotoxic ability of a sensitized 
recipient animal. Immunocompetent animals are sensitized 
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to an antigen (a peripheral nerve allograft) thus 
stimulating the production of cytotoxic elements which 
express antigen binding receptors specific for the antigen 
which stimulated their development. When the cytotoxic 
cells meet this antigen again (this time carrying a 
chromium 51 radioactive tag) the cells proliferate and lyse 
the antigen carrying cell thus releasing the chromium to be 
excreted in the urine of the animal where it can be easily 
measured [57]. In Mackinnon's experimental model, Lewis 
rats received 4.0 cm sections of Fisher, Buffalo, and ACI 
rat sciatic nerves [57]. Lewis and Fisher rats are known 
to differ only with respect to minor transplantation 
antigens whereas Lewis, Buffalo and ACI rats differ at 
. . . . . R1 
major histocompatability loci [74]. Results of the Cr 
assay showed sensitization with Buffalo and ACI nerve 
segments as early as day eight, whereas in the matched 
Fisher-Lewis grafts sensitization did not occur until day 
eighty. By contrast, skin allografts induced sensitization 
by day ten in all three strains. By day five, histological 
exam revealed the same dense cellular infiltrate in each 
group even when the histocapability was matched for major 
transplant antigens. The response in the latter group was, 
however, characterized as slower [57]. Although an immune 
reaction was seen histologically as early as day five in 
the Lewis-Fisher model none was seen by 51Cr assay until 
day eighty. The Cr assay depends on the presence of 
cytotoxicity and as such measures the functionally 
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significant components of the immune reaction. Since the 
assay has been previously shown effective in measuring 
sensitization in strains differing with respect only to 
minor transplantation antigens, Mackinnon et al. [57] 
concluded that these cells in the immune response though 
present histologically are less immunocompetent than cells 
involved in the response between strains with major 
antigenic differences. If valid, these findings would cast 
doubt on the reliability of histology to quantitate the 
immune response. 
In a recent study Mackinnon et al. [60] investigated 
the actual degree of regeneration that would occur across a 
nerve allograft actually implanted with microsurgical 
technique. They employed the same inbred rat strains as 
used in the previous immunological study judging nerve 
regeneration at five months by histological (axonal counts) 
and electrophysiological (nerve conduction velocity) 
measurements. The authors noted good regeneration in 
autograft and matched allograft groups and poor results in 
non-matched allografts. Mackinnon et al. concluded that 
these findings correlate well with both the 
histoincompatibility status of the donor and host animals 
and with the author's previous immunological study 
[57,60]. These findings do not correlate with those of 
Zalewski et al. [118,121], but do agree in respect to 
immunogenicity of minor antigenic differences with the 
findings of Singh [95,97]. Again, as in most the studies 
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in the literature, no attempt was made to describe 
experimental results with respect to functional return. 
Almquist [4] has shown the total lack of correlation 
between clinical results and nerve conduction velocity in 
man, thus, limiting the value of extrapolating electrical 
measurements obtained from experimental animals to presumed 
clinical application. 
In a separate study, Mackinnon et al. [59] addressed 
pretreatment methods used to decrease antigenicity of 
peripheral nerve allografts by using the same JXCr 
immunologic assay to determine quantitatively the nerve 
allograft response. Mackinnon looked at the effects of low 
and high dose irradiation, predegeneration, freezing with a 
cryoprotectant agent, lyophilization, and combination 
pretreatments in rats known to differ at the major 
histocompatibility locus [59,74]. They described these 
methods as having been used previously in clinical and 
experimental settings. As in previous work the donor 
nerves were not sutured in place but rather inlaid between 
the gluteal muscle fibers of the recipient rat [57]. 
Results showed that when the nerve received a high dose of 
irradiation or was lyophilized the immunological response 
did not differ from control autografts. They conclude that 
lyophilization and high dose irradiation can modify the 
nerve allograft in such a way as to render it less 
immunogenic while other pretreatment methods fail to do so 
[59]. It is interesting that Mackinnon chose to use a 
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cryoprotectant agent in her cryopreservation study while 
Singh [97,94,95] and Zalewski et al. [118] did not. It 
would have been useful to present data involving 
cryopreserved allografts prepared without a cryoprotectant 
agent. Verhoog and Van Bekkum had shown, in 1971, that 
high dose irradiation and freezing without a cryoprotectant 
kills cells, thus, rendering them non-antigenic [109]. 
From this one might conclude that these grafts frozen 
without cryoprotection would also prove less immunogenic by 
the 51Cr assay. It is obvious that lyophilization kills 
cells, thus, these three pretreatment methods are similar 
in that the allograft when transplanted is dead.Mackinnon's 
conclusions are therefore no different from those of 
Verhoog and Van Bekkum [109] thirteen years earlier. 
Complex immunologic assays addressing the immunogenicity of 
grafted segments have little to do with judging their 
functional ability to serve as more than a lifeless conduit 
for axonal regeneration. In an assessment of regeneration 
across lyophilized and irradiated allografts, Mackinnon et 
al. using previously described parameters [60] described 
regeneration as intermediate between that occurring across 
a fresh, untreated nerve allograft and that occurring 
across control autografts [58]. Pollard [80] had shown 
previously that results with autografts were superior to 
allografts as a result of the autografts ability to conduct 
a column of Schwann cells and regenerating axons to the 
periphery. 

Ruwe 29 
Mackinnon has shown through immunological studies that 
killing the cells of an allograft decreased its 
antigenicity [57,59] and in so doing she supports the 
results of previous investigations [13,14,29,64,65,85]. 
She failed, however, to prove that this has functional 
significance with respect to augumenting axonal 
regeneration. Ducker and Hayes, in 1970, had reported that 
allografts treated with such cytotoxic methods were only 
successful when used in lengths less than 4.0 cm [29]. 
In order to exceed these graft length limits and to 
more closely mimic the autograft response research needs to 
be directed toward preserving viable allogenic graft cells 
to potentiate axonal regeneration while decreasing the host 
response to these cells. 
In a series of papers dedicated to the role of the 
immunosuppressive agent cyclosporin A in the prevention of 
the rejection of peripheral nerve and Schwann cells in 
allografts, Zalewski, Gulati, and Silvers [115,116,119,12 0] 
reported their results from work done at NIH in the early 
1980's. They showed that nerve and Schwann cells survived 
in allografts in rats treated with cyclosporin A [116]. In 
separate work they demonstrated that host nerve axons 
regenerate through long nerve allografts and become 
insheathed by allogeneic cells if the host is 
immunosuppressed by rendering it tolerant at birth to the 
transplantation antigens of the nerve donor [121]. By 
innoculating lymphoid cells from specifically sensitized 
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isogeneic donors into tolerant rats, thus, abolishing 
immunologic tolerance, the authors precipitated rejection 
of the allogeneic Schwann cells as well as the regenerating 
host axons in the allograft [117]. In a recent paper, 
Zalewski, Silvers, and Gulati [122] investigated the extent 
of renewed axonal growth into the connective tissue 
remnants of rejected nerve allografts. Their goal was to 
investigate whether nerve segments in connective tissue 
continuity with the host nerve provides a framework for 
regeneration as in Mackinnon's and other models of 
pretreated allografts. The authors found, however, that 
the host axons only regrow into the most proximal part of 
the allograft. They conclude that viable allogeneic cells 
such as Schwann cells and fibroblasts together with the 
connective tissue matrix provide the best way to potentiate 
axonal regeneration through long allografts [122]. These 
findings support the need for establishing a reproducible 
and efficient way to store peripheral nerve allografts 
without killing allogeneic cells. 
C. Cryopreservation 
Controversy exists in the literature as to the role of 
cryopreservation in peripheral nerve allografting. Singh 
et al. [94,95,97] demonstrated that cryopreserved 
allografts could conduct regenerating axons. Zalewski, 
Gulati, and Silvers [118] failed in their work to support 
Singh's conclusions. Verhoog and Van Beckkum [109] showed 
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that freezing without a cryoprotectant agent as in Singh 
and Zalewski's work killed cells rendering then 
non-antigenic. Mackinnon [59] disclosed indirectly by 
51Cr immunological assay that peripheral nerve cells 
could survive if treated with cryoprotectant agents. 
Zalewski, Gulati and Silvers [122], in their most recent 
work, conclude that these viable allogeneic cells such as 
Schwann cells and fibroblasts are needed to provide the 
best way to potentiate axonal regeneration through long 
allografts. It is the goal of this research to explore 
optimal methods for preserving cell viability during 
cryopreservation and to employ cryopreserved grafts in a 
physiological manner in an effort to compare their 
effectiveness in potentiating axonal regeneration to that 
of nonpreserved autografts. 
Scientists have been exploring the effects of low 
temperature on biological and experimental models for 
centuries and have long contemplated the storage of living 
cells, tissues, organs and, even individuals for various 
medical and non-medical reasons. The concept of a 
cryoprotective agent is, however, a much more recent 
development. Keith [128], in 1913, reporting in Science 
was among the first to describe improved survival of 
microrganisms when frozen in milk, sugar, or glycerol 
solutions over those frozen in water or saline. Luyet and 
Hodapp [130] described improvement in frozen frog 
spermatazoa survival after pretreatment with a sucrose 
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solution. Other authors observed the protective action of 
sugars in erythrocytes subjected to rapid freezing. These 
early authors attributed the advantages of these treatment 
methods to non-specific effects such as providing channels 
between ice crystals in which cells might escape from being 
crushed [127]. In 1949, Polge, Smith, and Parkes [131], 
following studies involving the protection of spermatazoa 
and erythrocytes by glycerol, were the first to recognize 
and appreciate that specific compounds provided direct 
protection from some undefined parameter of freezing. 
Lovelock and Bishop [129] discovered later that 
Dimethylsulfoxide (DMSO) could effectively protect 
spermatazoa and erythrocytes from freezing injury and could 
serve almost universally as a protective compound. 
Doebbler [28] investigating the molecular structure which 
confers cryoprotective activity upon a substance found that 
multiple hydrogen-bonding sites per molecule markedly 
magnify an agent's protective capacity and that DMSO is an 
excellent hydrogen bond acceptor. 
Two main theories have surfaced to explain the 
protective mechanism of DMSO and other cryoprotectant 
agents. The first holds that by lowering the freezing 
point of solution DMSO prevents damaging ice crystal 
formation within cells. Intracellular ice formation has 
been shown to alter the spatial configuration of important 
intracellular molecules such as catalytic enzymes. The 
second theory maintains that DMSO acts by lowering the 
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temperature at which ice will separate out of solution and 
in so separating cause an increase in the concentration of 
the electrolytes in solution to levels which are toxic to 
the cells. The increased extracellular concentration 
results in an osmotic gradient with subsequent flow of 
water out of the cells leading to harmful concentrations of 
electrolytes [107] within the cells as well as to 
dehydration and consequent denaturation of cell proteins 
and destruction of cell enzymes and their enzymes patterns 
[52]. 
In an experiment designed to determine which of these 
two factors was the most important, Farrant [32] added 
solutions during cooling to prevent the concentrations of 
solutes in the liquid phase from rising above normal 
values, both in the presence and absence of ice crystal 
formation. In order to prevent ice crystal formation at 
temperatures as low as minus 80° C, some of the solutions 
included DMSO in very high concentrations. Farrant found 
each method either with or without ice crystal formation to 
protect mamallian muscle tissue from cryo-damage and, thus, 
concluded that the increase in electrolyte concentrations 
to toxic levels was more important and its prevention was 
the protective action offered by DMSO and other agents 
[32]. 
Addressing Farrant's results, Karow, Carrier, and 
Holland [47] demonstrated that exceedingly high 
concentrations of DMSO needed to prevent ice crystal 
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formation were unnecessary and toxic in rat heart 
preparations when used in concentrations greater than 25 
percent DMSO. 
In a study involving the role of DMSO as a 
cryoprotective agent for peripheral nerve tissue, Lenz et 
al. [52] applied a silver cryoprobe to the sciatic nerve of 
rabbits in vivo, one-half of which had been pretreated with 
a 10 percent DMSO solution. By macroscopic observation, 
electrophysiological measurements, and histological 
examination, Lenz concluded that DMSO was effective in 
reducing the damage caused by the freezing process in 
peripheral nerves which had been pretreated with a 10 
percent solution. 
In later work, Farrant et al. [33] investigated the 
role of a two-step cooling procedure first described by 
Luyet and Keane in 1955 in examining factors influencing 
cell survival following freezing and thawing of Chinese 
hamster lung fibroblasts. Farrant, using a 5 percent DMSO 
solution, measured survival by a cell colony assay and 
examined the ultrastructure of the cells to determine the 
degree of cellular shrinkage and the location of 
intracellular ice. Farrant found that cellular shrinkage 
induced by holding at -25° C to -35° C for ten minutes 
correlates with protection from injury. Alternatively, 
rapid cooling without holding at sub-zero temperature 
induced intracellular ice formation. In thawing rate 
experiments, Farrant et al. found an increased sensitivity 
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to injury as a result of slow thawing which was most marked 
in the case of rapidly cooled cells and, thus, linked such 
injury to intracellular ice formation. In conclusion, 
Farrant et al. suggests that injury occurs during rewarming 
and is osmotic in nature. 
In a recent article, Tomford et al. [106,107] reported 
the results of investigations on the effects of DMSO and 
glycerol on chondrocytes as well as the ability of this 
cell to function normally after freezing. The authors' 
found that at 4° C neither cryoprotectant produced toxic 
effects unless their concentration was greater than 12 
percent or exposure time greater than ninety minutes. 
Using the previously established two-step cooling 
technigue, they combined various pre-maximal freezing 
temperatures with various exposure times. The optimal 
freezing technique for cells previously exposed to DMSO as 
judged by trypan blue dye exclusion was when chondrocytes 
were cooled to -40° C for five minutes before 
flash-freeze to -80° C. Survival in cells pretreated 
with DMSO approximated 95 percent while control survival in 
untreated cells was 60 percent. To evaluate the metabolic 
products of fresh and frozen chondrocytes, the authors 
placed surviving cells in culture and found that cells 
remaining in culture for seventy-two hours after thawing 
produced aggregated proteoglycans similar to those made by 
fresh chondrocytes. 
Tomford et al.'s dog chondrocyte results are similar to 
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those of Farrant [33] working with Chinese hamster lung 
fibroblasts. In both systems a first stage cool to 
-35° C to -40°C before deep freeze coupled with a rapid 
thaw produced good functional results [33,106,107]. 
The established two-step freezing technigue will be 
used and the temperature and thawing parameters established 
by Tomford and Farrant tested in our experimental model of 
nerve cryopreservation of peripheral nerve autografts in 
the rat. 
D. Animal Model 
A superlative regenerative capacity in peripheral 
nerve injury has been suggested in the rat which Mackinnon 
et al. [123] claims to undermine the validity of studies 
investigating factors used to evaluate nerve regeneration. 
Mackinnon further states that controversey exists over the 
appropriateness of the rat as an experimental model for 
studying peripheral nerve injury, repair, and 
regeneration. The authors cite two sources to back their 
claim. The first, a 1964 study by Kline, Hayes, and Morse 
[50] comparing the response of species to peripheral nerve 
injury and, the second, a 1982 letter to the editor which 
paraphrased Kline et al.'s results [37]. 
In their study, Kline et al. [50] carried out neural 
crush and severance with primary suture repair in a series 
of dogs, monkeys, baboons and chimpanzees. They compared 
results by histological exam, electrophysiological studies, 
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and axonal counts. The authors conclude that differences 
exist in species in response to peripheral nerve injury, 
specifically with respect to connective tissue 
proliferation in phylogenetically higher animals. However, 
in each comparison performed at two to six week intervals, 
the authors presented data from only one animal in each 
group. Futher reported differences were concluded by 
subjective criteria alone. In addition, despite these 
apparent differences of species in the pattern of 
regeneration, differences in axonal counts were never 
statistically significant among the four species in either 
the crush or severence with primary suture repair model. 
Obviously when experimental results are to be applied to 
humans, it is best to utilize higher primates as models, 
but it would not seem warranted by the above conclusions 
alone to abandon the rat model which offers an inexpensive 
and relatively unlimited source of mammalian nervous tissue 
which even at the electron microscopic level is 
indistinguishable from human peripheral nerve. 
In a stated recent attempt to lend perspective to the 
significance of previous studies and perhaps to serve as a 
control for future studies, Mackinnon, Hudson, and Hunter 
[123] investigated the degree of spontaneous regeneration 
that occurs in the sciatic nerve of rats five months after 
complete resection. Histological examination in thirty- 
adult Lewis rats five months after sciatic nerve excision 
revealed an average proximal to distal regeneration of 23.7 
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mm + 6.4 mm. Histologic sections taken at 1.0 cm intervals 
along the regenerated nerve segments revealed evidence of 
compartmentalization and "minifascicle" formation. 
The findings of this study are interesting when 
compared to contradictory results from other independent 
studies in the literature involving spontaneous bridging of 
peripheral nerve gaps. Lundberg et al. [54] comparing the 
anatomical and functional regeneration of a transsected 
sciatic nerve following regrowth from its proximal stump 
through either preformed empty mesothelial chambers or 
autologous nerve grafts found little or no regeneration 
when a 1.0 cm gap between the nerve stumps was left empty 
in Sprague-Dawley rats. 
Bucko and Steinmuller [14] studying reinnervation of 
tail muscles after orthotopic grafting of peripheral nerve 
segments in inbred rats found in their control series of 
nineteen animals that none were able to spontaneously 
bridge a 3.0 cm gap to reinnervate tail muscles during an 
eleven month period of observation. 
Ducker and Hayes [29] investigating autograft 
limitations in dogs and chimpanzees found each incapable of 
spontaneously bridging a control gap of 2.0 cm. Contrary 
to their prior conclusions, it seems impractical to 
extrapolate Mackinnon's results [123] to serve as controls 
for unrelated studies of peripheral nerve regeneration as 
evidenced by the aformentioned gap studies. Many known and 
unknown factors are involved in the regeneration of 
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peripheral nerve tissue in various experimental systems. 
It would, therefore, seem most efficacious to eliminate 
unnecessary variables by utilizing gap animals unigue to 
each experimental model as controls against spontaneous 
bridging of peripheral nerve defects and to guantitate 
specific regenerative capacity. 
E. Physiology of Repair 
Many studies have been performed and various 
techniques devised to address the need to optimize the 
suture line and, thus, potentiate regeneration across 
proximal and distal stumps in peripheral nerve grafting. 
Studies have shown that even in cases of peripheral nerve 
repair under the most optimal of conditions that a small 
zone of fibrosis or scar tissue developed between the 
repaired nerve ends which needed to be tranversed by 
regenerating axons. This phenomena is especially important 
in the case of free nerve grafting when not one, but two 
suture lines need be crossed. Berger and Millese [11] as a 
result of their experience in animal experiments and 
clinical practice have shown that regenerating axons can 
cross two optimal suture lines more easily than one poor 
one. Through their work, they have defined conditions to 
optimize the suture line as follows. Firstly, that no gap 
be present between the proximal and distal stump after 
repair. Secondly, that there be only minimal tissue 
proliferation at the site of anastomosis. And thirdly, 
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that there be optimal coaptation of major fasciculi or 
groups of minor fasciculi between the graft and host 
tissue. From their large series of experimental and 
clinical cases, Millesi and Berger [71] have further 
identified the most important negative factor influencing 
the results of nerve repair carried out under the 
aforementioned optimal conditions as tension at the suture 
site. Results and recovery rate are statistically better 
if tension is avoided. 
The advent of the operating microscope coupled with 
fine surgical instruments has afforded modern surgeons the 
ability to place extremely fine #10-0 and #11-0 epineural 
and perineural sutures. This minimizes surgical trauma to 
the nerve and permits precise anatomical alignment of 
severed stumps. However, suture material acting as a 
foreign body may evoke fibrous tissue formation which 
Berger and Millesi [11,71] have shown to adversely affect 
axonal proliferation. In an attempt to eliminate this 
foreign body reaction, some authors [29,118,121,12 0] have 
performed neuroplasty utilizing fibrin gluing or clotting 
techniques which mimic the natural coagulation process at 
the anastomotic site. In an attempt to compare the 
efficacy of these two methods of neuroplasty, Becker, 
Gueuning, and Graff [9] performed peripheral nerve 
anastomoses utilizing the rat sciatic nerve as a model 
using either epineural sutures or a fibrinogen adhesive 
technique. Using radiolabelling of the metabolically 
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active acid-soluble phosphate fractions of nerve and muscle 
and comparing gastrocnemius and soleus muscle weight in a 
number of experimental situations Becker et al. [9] showed 
that labelling of the sutured and glued nerves was not 
significantly different with the return to control values 
proceeding at the same rate. In addition at 60 and 150 
days there was no significant difference in innervated 
muscle weights between the suture and fibrin glue groups. 
Both repair methods were shown to be equally inferior to 
the spontaneous recovery which occurs after simple nerve 
crush injury. 
In an interesting study designed to determine the 
effect of nerve graft polarity on nerve regeneration and 
function, Stromberg, Vlastou, and Earle [103] found by 
direct conduction velocity and amplitude studies that nerve 
graft function was statistically independent of nerve graft 
polarity. This finding, though not directly related to the 
current study, decreases the possibility that a reversal of 
orientation during either storage or reimplantation of the 
autograft would affect our experimental model and the 
interpretation of results. 
deMedinaceli, Wyatt, and Freed [25,26,34] working in 
response to the resultant gap which results from 
neuroplasty using either nerve suturing or gluing with 
blood or blood protein have devised a highly complex 
technique designed to address some of the conditions as 
defined by Berger and Millesi [11] which affect the 
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regeneration of axons at sites of anastomosis. Their 
technique considered seventeen factors of which the major 
ones were proper alignment of the stumps, sharpness of the 
cut and prevention of physical and chemical damage to the 
severed nerve. In their procedure, which they term nerve 
reconnection, the transsected nerve stumps are sutured to a 
rubber support in an overlapping fashion. The nerve is 
bathed in a modified Ringer's solution to prevent the 
interior of the nerve fiber from losing its chemical and 
ionic balance. Next, the nerve is cooled and the ends 
trimmed with a vibrating razor blade to assure a sharp 
transsection of the axons with minimal resultant crush 
injury. The tension on the rubber support is then released 
until it pushes the nerve ends together with just enough 
pressure to hold them in place without distorting them. 
The temperature is then raised and the ends of the rubber 
support are sutured together. They report results in the 
rat based on functional criteria (which will be further 
explained in the next section) in reconnection technique 
which were 66 percent better than that of animals treated 
by conventional microscopic technique [25], and suggest the 
use of this method to improve the return of function after 
peripheral nerve injury in humans. Unfortunately, 
deMedinaceli,s technique is a long and highly complex 
procedure which requires extensive dissection, disruption 
of neural circulation, application of freezing and 
nonphysiological solutions, removal of a portion of the 
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nerve itself, insertion of a foreign body which requires a 
second operation for removal and a surgically ideal 
clinical situation of transverse nerve transsection without 
associated local injury. The procedure's clinical 
usefulness is limited by tension at the repair site; the 
very problem it attempts to address. In addition, no 
attempt has been made to use nerve reconnection in the case 
of segmental loss requiring an autograft or allograft. 
In light of these limitations and with respect to 
equivocal findings with respect to fibrin gluing and 
suturing, we have chosen to employ conventional 
microsurgical suturing technique in our experimental model. 
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F. Methods for Assessing Regeneration Following 
Grafting 
1. Functional Recovery 
In the evaluation of the relative efficacy of various 
types of peripheral nerve grafting procedures or 
pretreatment technigues, it is clear that the most 
important criteria for judging recovery in meaningful terms 
would be return of function to the reinnervated limb. 
Although easily assessed in man, functional recovery is 
difficult to measure in experimental animals. In 1982, 
deMedinaceli, Freed, and Wyatt [24], realizing that no 
widely accepted guantitative method existed to evaluate the 
functional effects of peripheral nerve damage in animals, 
devised a method for evaluating sciatic nerve damage from 
measurements of the foot prints of the hind foot of walking 
rats. From the walking tracks they measured four variables 
to which they compared the operated to control leg and 
converted their findings into percent deficits which they 
averaged to obtain what they termed a "sciatic functional 
index" (SFI). 
The method of deMedinaceli et al. involves testing 
animals in a confined walkway with a dark shelter at one 
end. A piece of unexposed x-ray film is placed along the 
floor of the corridor and the animals' hind feet are dipped 
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into a developing fluid. As the animal walks down the 
corridor, paw prints appear immediately on the film. Three 
or four prints from each foot typically appear on film from 
which the authors measured four variables. The first 
measured variable is the distance from the tip of the 
experimental foot to the tip of the following contralateral 
toes. This variable measures the capacity of the 
experimental leg to support the animal's weight. The 
second variable measured the length of a foot print (PL). 
This length is short in normal animals which walk only on 
their toes and longer in animals with neural deficits. The 
third variable measured the linear distance between the 
first and fifth toes and defined this variable as the toe 
spread (TS). The final variable measured the toe spread 
between intermediary toes as the linear distance between 
the second and fourth toes (IT). The latter two variables 
served as an indicator of the condition of the peroneal 
branch of the sciatic nerve. From these variables, 
deMedinaceli et al. devised an empiric formula based on the 
assumption that all four variables were egually important. 
The authors tested their index in animals receiving a sham 
operation, a Ringer's injection into the sciatic nerve 
trunk, a neural crush injury, and transsection with 
immediate suture repair. They found the speed of 
functional recuperation observed by the SFI to be 
consistent with established values for other methods 
[27,39]. Recovery was observed in the injected nerve by 
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the second day, whereas the sham operation did not effect 
the S FI from normal values. The crush injury nerves 
recovered preoperative values by the thirty-second day 
postoperatively while the severed and repaired nerve showed 
no statistically significant recovery at thirty-two days. 
The authors concluded that the sciatic functional index 
provides a precise and reliable assessment of rat sciatic 
nerve recovery [24]. 
deMedinaceli's results apply nicely to the situation of 
minor nerve injury or crush injury when the nerve 
architecture is injured but maintains its support 
architecture. They, unfortunately, did not report data 
from their group with repaired transsected nerve injuries 
past thirty-two days postoperatively. The authors further 
used many "adjustment factors" and extrapolation formulas 
to account for animals who suffered self mutilation or 
whose values fell outside of established guidelines. It is 
possible that the SFI does not apply readily to situations 
involving major nerve injury due to the introduction of 
more variables such as flexion contracture or 
self-mutilation. We will investigate this in our study by 
applying the SFI to animals which have received sciatic 
nerve autografts. 
2. Electrophysiological Studies 
Secondary to the inherent difficulties involved with 
neurological examination of experimental animals involving 
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its lack of objectivity and its potential to lead to biased 
results, many authors have used direct electrophysiological 
measurement of the nerve graft segment in the form of 
evoked muscle action potentials and in vivo nerve 
conduction velocity measurements to draw functional 
conclusions from their grafting experiments [14,29,56,60, 
81,82,83,94,95,96,97]. Although some authors have found 
progressive recovery of compound muscle action potential in 
experimental animals, they have had difficulty describing 
results in objective terms referring to wave forms as 
relatively normal, though of reduced size [81]. Because of 
these problems, difficulties eliminating cross talk, and 
troubles with the elimination of other tissues that can 
conduct eletrical impulses, most of the investigators 
[29,56,81,94] have turned to nerve conduction velocities to 
quantitate recovery. In these experiments, the nerve graft 
is exposed and the sciatic nerve stimulated through paired 
silver wire electrodes placed beneath the nerves. The 
maximum conduction velocities of the graft are determined 
from the latency of the proximal and distal stimulating 
points to the muscle and the conduction distance. 
MacKinnon [56,60] and Pollard [81,82,83] used conduction 
times to support their conclusions while Singh 
[94,95,96,97] used conduction velocity results to divide 
his animals into four EMG grades of decreasing velocities. 
Unfortunately, Almquist and Eeg-Olofsson [4], in their 
study of nineteen patients, have shown in their 1970 
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article relating nerve conduction velocities to two-point 
discrimination in sutured nerves that there is no 
correlation between the clinical results as measured by the 
functional two-point discrimination test and the nerve 
conduction velocity. Therefore, the maximum conduction 
velocities studied had no functional significance as 
purported by the aforementioned investigators [14,29,56,60, 
81,82,83,94,95,96,97] and their findings should not be 
extrapolated to possible human application. For these 
reasons, EMG studies will not be performed in our 
experimental model. 
3. Sensory Testing 
Although sensory testing is an excellent marker in 
humans for functional return, it is subjective and 
unreliable in animals such as the rat. Even a positive or 
negative response to painful stimuli is difficult to 
interpret in light of cutaneous reinnervation following 
peripheral nerve injury and repair, secondary to the 
expansion of the functional distribution of intact 
neighboring fibers of uninvolved nerves. For these 
reasons, investigators have not used sensory return as a 
criteria to judge their results in peripheral nerve 
allograft experiments. Devor, Schonfeld, Seltzer, and Wall 
[27] have reported recently on their work involving 
cutaneous reinnervation following peripheral nerve injury 
which could in an altered form be used to make conclusions 
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concerning the recovery of sensation in the distribution of 
the sciatic nerve in rats. Cahal [17] had shown in 1928 
that the mechanism of return of sensate function involves 
movements of two interacting populations of axons: 
regenerating fibers from the severed nerve and sprouts 
emitted by intact fibers in the skin surrounding the 
denervated zone. Devor et al. [27] investigated these 
movements behaviorally and electrophysiologically in rats 
with experimentally induced crush injuries or permanent 
nerve section of rat sciatic nerve. The foot in the rat 
receives its cutaneous sensory innervation along the 
saphenous nerve (an extension of the femoral nerve) and the 
sciatic nerve. Devor et al. determined the normal 
distribution of each nerve by cutting the other and mapping 
the regions of sensory loss and remaining sensibility. 
They found the saphenous nerve to innervate only the dorsal 
aspect of the medial toes. By studying changes after crush 
of the sciatic nerve with the saphenous nerve intact or 
ligated, they further show that the early phase of 
sensibility recovery is attributable to invasion by 
branches of the intact saphenous nerve (four days) 
resulting in expansion of its distribution and the later 
phase to regeneration of the sciatic nerve itself (twenty 
days). Detailed observations were made on rats in which 
the sciatic nerve was severed and regeneration prevented. 
The authors found that the area of responsive skin began to 
increase within four days as before, but after fifteen to 
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thirty days stopped short without returning to the lateral 
most toes (toes five, four, and most of three). 
Accompanying this functional expansion, the authors 
discovered expanded saphenous nerve receptive fields 
consisting of high threshold mechanoreceptors. With return 
of function of the sciatic nerve, the expanded distribution 
of the saphenous nerve went back to its original 
boundaries. The authors concluded that cutaneous 
reinnervation begins with collateral expansion of high 
threshold afferents from intact neighboring nerves which 
are later replaced upon regeneration of the original 
nerve. Devor et al. did not see or investigate the 
possible application of their findings to the nerve graft 
model. Based on their findings that the saphenous nerve 
does not reach to reinnervate the lateral toes, we can show 
that in the nerve grafted animals return of sensibility to 
the lateral foot is solely the result of reinnervation via 
the sciatic nerve graft. In fact, we can follow lateral 
sensation return in experimental animals as an early index 
of sciatic functional sensory return giving us an objective 
test of functional recovery. 
4. Hydroxyproline Assay 
The hydroxyproline content of animal tissue is thought 
to be confined almost exclusively to the connective tissue 
scleroproteins, collagen and elastin. Hydroxyproline 
concentration has, as a result of this restricted 
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distribution, been used as an indicator of both the 
presence and the metabolism of collagen. Historically, the 
most commonly used quantitative assay for hydroxyproline 
was that of Neuman and Logan [73]. Unfortunately, their 
assay was highly susceptible to interference from other 
amino acids in the hydroxyproline containing samples and 
not sensitive to low levels of hydroxyproline in tissue 
samples. In 1961, Woessner [112] addressed these problems 
in developing a method for the quantitative determination 
of hydroxyproline concentration in biological materials 
containing as little as one part of hydroxyproline in four 
thousand parts of amino acid. Reporting at the Orthopaedic 
Research Society in 1986, MacDonald et al. [56] described 
their findings involving hydroxyproline quantitation in 
normal muscle and denervated muscle after immediate and 
delayed nerve repair using the Woessner assay. 
Intramuscular hydroxyproline levels are known to be a 
direct indication of collagen content. 
Acetylcholinesterase and elastin are the only muscle 
proteins which contain significant amounts of 
hydroxyproline, less than one percent by weight. In 
studies undertaken to determine whether overall increases 
in intramuscular collagen follow denervation and 
reinnervation, MacDonald et al. found that functionally 
successful immediate nerve repair results in a doubling of 
intramuscular hydroxyproline content in three months. 
Muscles from nonfunctional delayed repairs show a five-fold 
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increase over normal hydroxyproline levels and a two-fold 
increase over cases involving immediate repair. In all 
cases, there was correlation between function and collagen 
content, with increase in fibrosis indicating poorer 
functional recovery. Our study will incorporate Macdonald 
et al.'s findings. By assessing tibialis anterior muscles 
from experimental and control legs in each group we will 
use the hydroxyproline concentration as another method to 
judge functional recovery. 
5. Axonal Counts 
Traditionally axonal counting methods have been 
employed to assess the degree or efficacy of axonal 
transmission through nerve graft segments from the proximal 
to distal stump. Well myelinating fibers have been 
correlated with electrophysiological evidence of 
regeneration. Many histological quantifications have been 
made from results of axonal counts from regions proximal, 
within, and distal to grafted segments. In addition to the 
objective number of myelinated nerve fibers, fiber 
diameters and percentage of neural tissue have been 
described. In the case of allografted tissue, comments 
have also been made concerning inflammatory or graft 
rejection phenomena. While axonal counts are useful in 
assessing axonal transmission, they do not account for 
possibilities such as a single proximal axon being 
represented by more than one axon in the distal 
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segment. More importantly, no direct functional 
correlation may be drawn from results of axonal counts. 
Axonal counts as an indicator of axonal ingrowth can 
however be inversly correlated with graft rejection or 
death of graft Schwann cells. Realizing these limitations 
and their application, we will conduct axonal count 
studies, the results of which will be applied to more 
functionally objective criteria. 
G. Conclusion to Review of the Literature 
Finally, in assessing the relative merits of different 
types of grafting procedures, care must be taken to 
evaluate the extent of recovery in functionally meaningful 
terms. Some authors have devised experimental models in 
which they performed only proximal anastomoses [118,120,122]. 
Others have placed 4.0 to 5.0 cm grafts into 0.5 cm 
deficits requiring graft segments to be looped around 
within the experimental animal's leg [61,118,122]. Still 
others have implanted nerve segments in ectopic regions 
[13,19]. Clearly, these models do not present functionally 
significant data. Most investigators have used some form 
of axonal counting and/or electromyographic study alone to 
draw conclusions from their results [14,29,57,59,75,83,95]. 
The dangers of extrapolating data to the human model have 
been previously discussed. In this study, we shall 
approach interpretation of our data from a multifaceted 
analysis combining traditional methods with those newly 
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devised. We will combine pure functional studies with 
sensory, histological, anatomical, and biochemical analysis 
in an attempt to maximize the validity of our experimental 
results and in such potentiate the comparison of 
experimental results to possible clinical usefulness while 
realizing the limitations of extrapolation. 
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III. Material and Methods 
A. Animal Model 
Adult male Sprague-Dawley rats weighing 300 to 320 gm 
were purchased from Cam Breeding Laboratories (Wayne, New 
Jersey). All animals were maintained in plastic lined 
cages in a central animal care facility (FMB-05) and 
received water and rat chow ad libitum. The animals' daily 
diurnal cycle was set at twelve hours light followed by 
twelve hours darkness. Three experimental groups were 
used. The first control grafted group (n=ll) received a 
2.0 cm fresh autograft. The second cryopreserved grafted 
group (n=12) received a 2.0 cm cryopreserved graft. The 
third gap nongrafted group (n=13) was left with a 2.0 cm 
deficit in one sciatic nerve. 
B. Surgical Procedures 
Autograft technigues were chosen in an attempt to 
minimize the role of histoincompatibility in this model. 
Even inbred rat strains have some minor histocompatibility 
differences which could adversely affect our results 
[126]. The right or left sciatic nerve of three groups of 
fifteen animals was exposed through a gluteal muscle 
splitting incision. The animals were unselected and 
randomly assigned to treatment groups. Only one side of 
each animal was operated upon. The other rear leg served 
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as an internal control for each animal. The sciatic nerve 
was then exposed in its length from the sciatic notch 
proximally to the distal muscular branches in the region of 
the popliteal fossa. A 2.0 cm segment of sciatic nerve 
beginning proximally 0.5 cm from the sciatic notch was 
resected. In the eleven animals compromising the control 
group, the 2.0 cm sciatic segment was left with its 
vascular pedicle intact and each of its ends were tacked 
down to local muscle fascia using microsurgical technique 
(operating microscope JK-Hoppl Company, Model No. 029001) 
with one epineural suture of #10-0 nylon (Dermalon, 
American Cyanamide, Pearl River, New York) to maintain its 
length. 
In the twelve animals comprising the cryopreserved 
group, the 2.0 cm segment was first suspended using 
microsurgical technique to a micro-clamp with two #10-0 
sutures and then placed into sterile tubes containing 
culture media that consisted of 90 percent DulBeccos 
modified Eagle's medium, supplemented with 10 percent fetal 
calf serum and containing 10 percent sterile DMSO as an 
anticrystallizing cryopreservation agent. After four to 
five minutes in this medium, the micro-clip containing the 
nerve was removed and placed into a separate, sterile 
freezing vial (NUNC 4.5 ml Cryotube, West Germany). The 
vial was immersed for 300 seconds in an acetone bath 
maintained at -40° C. The temperature of the bath was 
constantly monitored by a cryoprobe. The vials were then 
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stored at -80° C in a Revco freezer for three days. In 
preparation for reimplantation, the nerve segments were 
rapidly thawed in lactated Ringer's at 37° C for three 
minutes. 
In the thirteen animals comprising the gap group, the 
2.0 cm sciatic segment was removed and used for 
histological studies of normal axon counts. The values 
obtained, expressed in terms of axonal density, were 
compared with counts obtained from similar sections cut 
through the graft segment of the fresh and frozen nerve 
graft segments at the time of sacrifice. The two ends of 
the resultant gap were sutured to fascia with #10-0 suture 
utilizing microsurgical technique at a gap distance of 2.0 
cm between proximal and distal segments. In all groups, 
the gluteal muscle was approximated and the skin closed 
with #3-0 Dexon. 
At seventy-two hours, the control group underwent a 
second operation at which, using microsurgical technique, 
an epineural repair was carried out using four sutures of 
#10-0 nylon. Physiological realignment of the proximal and 
distal segments was achieved by marking the stumps at the 
time of the original procedure with blue dye (methylene 
blue chloride, H.J. Conn, Geneva, New York) and by 
realigning surface vessels. The vascular pedicle was then 
separated. The repair was the same in the cryopreserved 
group. The gap group received a sham operation, at which 
time the sciatic nerve was exposed. Again, the gluteal 
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incision was approximated and skin closed using #3-0 
Dexon. All operations were performed using aseptic 
technigue in the Orthopaedic Surgery Operating Laboratory. 
All animals wounds were treated with Povidine Prep Solution 
(ACU-dyne, Fairfield, Conn.) prior to final closure. The 
anesthetic used was pentabarbital sodium (30 to 40 mg/kg, 
Abbott Laboratories, Quebec) administered 
intraperitoneally. 
C. Functional Testing 
The animals were observed two to three times a week to 
identify any wound or ulcer complications. In addition, 
the animals were followed by Serial Gait Testing 
preoperatively and at two-week intervals throughout the 
course of the experiment. The animals' gait testing was 
conducted in a confined walkway fifteen inches wide by 
fifty inches long with a dark shelter and peanut butter 
reward at the far end. This design is a modification of 
that described by deMedinaceli [24]. After one or two 
conditional trials in which the rats stopped to explore the 
corridor and later in the course without any trials, the 
rats walked steadily to the shelter and reward at the end 
of the darkened corridor. A piece of unexposed x-ray film 
(Kodak X omat TL Film, Eastman Kodak, Rochester, New York) 
cut to the proper dimensions was placed on the corridor 
floor. The rats were then held in one hand while applying 
developer (Dektol, nondiluted, Eastman Kodak, Rochester, 
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New York) to the animals hind feet with a dampened sponge. 
The animal was placed at the entrance to the corridor and 
walked steadily along the x-ray film causing paw prints to 
appear immediately on the film. 
Three or four prints of each foot appeared on the 
length of the film used. Three variables were measured on 
the control and operated paw prints. The toe spread (the 
linear distance from the center of the print of the first 
toe to the center of the print of the fifth toe) 
measurement on the experimental side was expressed as a 
percentage of the corresponding value measured on the 
control side. The other parameters measured were the print 
length (the length of one foot print) and the distance 
between the intermediary toes (the linear distance between 
the centers of the second and fourth toes). All values 
were measured to the nearest millimeter (see Tables 1-3). 
To test the reproducibility of the index, forty-five tracks 
selected at random were measured by two observers who were 
not previously trained. Their results were compared with 
those obtained for the same forty-five tracks by the 
principal observer. 
At the time of sacrifice while under anesthesia, each 
animal's hind foot passive range of motion was assessed in 
the normal and operative leg and degree of extension 
measured with a goniometer. To test the reproducibility of 
the measurements, four nonselected animals in each group 
were measured by an observer not previously trained. His 
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results were compared with those obtained by the principal 
observer. 
D. Sensory Testing 
The rats' feet were examined preoperatively and at 
close intervals after surgery. At two week intervals 
concurrent with gait testing experiments sensory 
examinations were performed. In these tests, the animal 
was minimally restrained, the leg was grasped gently and 
six predetermined sites on each foot were examined for 
response to pressure or pinch stimuli applied to the skin 
using an Addison's forcep. Each site was graded on a scale 
from zero to three indicating: O) no response even to 
strong grasping of the skin, 1) vocalization or withdrawal, 
but only upon strong pinching, 2) vocalization or 
withdrawal with moderate pressure, but less reliably or 
more sluggishly than with the same stimulus in the mirror 
spot on the contralateral nonoperative foot, and 3) normal 
response defined as equal to that obtained in the same spot 
on the contralateral leg. In accordance with this 
classification, the animals' reactions were graded and 
reported on a scale from zero to eighteen. At the time of 
sacrifice, animals while lightly anesthetized were again 
tested as above, but now in a highly controlled 
experimental conditions. To test the reproducibility of 
the index, fifteen animals selected at random were tested 
by an observer with no knowledge of the experimental 
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design. His results were compared with those obtained by 
the principal investigator. These tests provided reliable 
and reproducible results. 
E. Hydroxyproline Assay 
Following re-exploration and harvest of the nerve 
graft segment, attention was directed to the muscles of the 
anterior compartment of the rats' experimental and control 
legs. A midline incision was made from the superior aspect 
of the patella to the first web space medial to the great 
toe, and the tibialis anterior and the extensor digitorum 
longus muscles were identified and harvested at their 
origins taking care to divide their tendon insertions at 
the level of the inferior extensor retinaculum. The 
muscles were weighed (Satorius Analytical Balance Model No. 
2603, West Germany) to the nearest .00005 gram on an 
analytical balance and frozen at -10° C in a sterile 
cryotube for later analysis. 
In each of the three experimental groups studied 
intramuscular hydroxyproline in each of the rats tibialis 
anterior muscles was quantitated at three months following 
the initial procedure by the procedure of Woessner [112]. 
Muscles to be assayed for hydroxyproline were first thawed 
and then stripped of tendon and surface connective tissue. 
Two 30 to 50 mg pieces of muscle (wet weight) were taken 
from a specific site on each muscle, stripped of any tendon 
strands, weighed analytically (Sartorius, West Germany) and 
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placed in Corning Pyrex tubes with Teflon caps (American 
Scientific Products). Macdonald et al. [56] have shown 
that the distribution of hydroxyproline in normal muscle 
differs with respect to location within the muscle with the 
proximal and distal lesions of the muscle containing the 
highest levels of hydroxyproline. By sampling in the same 
location on each muscle this variance was eliminated. 
After the addition of 1.5 ml of six N hydrochloric acid, 
the tubes were placed in a bacteriological incubator (B 
Blue Electrical Company, Model No. 100-A, Blue Island, 
Illinois) where the tissues were hydrolized at 110° C for 
eighteen hours. After allowing the tubes to cool, Methyl 
Red indicator (Fisher 0.02 percent solution) was added 
followed by 3.6 ml of 2.5 normal NaOH added drop wise until 
the solution turned straw colored. This color change 
corresponds to a pH of between 6.0 and 7.0. Final 
adjustments were made with dilute HCL and NaOH. The 
samples were compared with the standard water tube marked 
to a volume height of 15 ml and H20 was added to bring 
each sample to volume. A stock solution of hydroxyproline 
(Aldrich S. L/HP440-9) was used to prepare standard 
dilutions containing from one to five mg hydroxyproline per 
2.0 ml volume to be quantitated as controls 
spectrophotometrically (UV Spectrophotometer Model No. 
1332, Beckman Instruments). A linear relationship has been 
shown between absorbency at 561 nm and hydroxyproline 
concentration [112]. The experimental samples were diluted 
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in a similar manner in two volumes to contain 
hydroxyproline concentration within the standard curve. 
One ml of Chloramine T Fisher (0-1779 reagent grade) was 
next added to the samples to initiate hydroxyproline 
oxidation and allowed to incubate for twenty minutes at 
room temperature. Next, one ml of perchloric acid (Fisher 
A-229 reagent grade) was added to each sample in order to 
destroy the chloramine T. After five minutes, one ml of 
dimethylamino benzaldehyde (DAB Fisher D71/100) was added 
and samples were incubated in a hot water bath at 60° C 
for twenty minutes. The hydroxyproline content of the 
samples was then quantitated spectrophotometrically against 
the standard hydroxyproline curve. Hydroxyproline 
concentration in ug/mg wet weight of rat tibialis anterior 
muscle was then calculated and values expressed as a 
percentage of the internal control (nonoperative leg). 
F. Histological Studies 
Three months after the initial procedure, the nerve 
grafts of all experimental animals were re-explored, 
harvested, and fixed in four percent gluteraldehyde 
cacodilate buffer at pH 7.4 overnight at 4° C. The 
tissue was then washed with cacodilate buffer with sucrose 
and post-fixed with one percent osmium tetroxide in 
cacodilate buffer and dehydrated in graded alcohol. The 
tissue was then imbedded in epon according to Lufts Formula 
No. 1. The samples were sectioned with an ultra-microtome 
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(LKB Huxley, AB Bromraa, Sweden) with a glass knife and 
one-half to one micron thick sections were prepared and 
examined by light microscopy. Ultra thin sections were 
also cut with the ultra-microtome stained with uranyl 
acetate and lead citrate and examined on a Philips P-200 
Electron Microscope (Philips Electronic Instruments, Mt. 
Vernon, New York). Nerve segments harvested from gap 
control nongrafted segments were processed at the time of 
removal by the same methods. The animals were sacrificed 
by carbon dioxide inhalation. 
All animals in each group were studied by light 
microscopy. Two animals in each group were studied by 
electron microscopy. Sections were taken from the sciatic 
nerve proximal to the nerve graft, through the proximal, 
middle and distal graft, and distal to the nerve graft. 
Sections taken proximal to the graft were used as internal 
controls. Using the Osteo-Plan (Zeiss, Inc., West Germany) 
photographic enlargements were made of each nerve segment. 
These enlargements were used to count the total number of 
myelinated nerve fibers in each nerve segment. In 
addition, nerve cross sectional area and perimeter were 
calculated according to a program for such calculations by 
the Osteo-Plan. 
The gap animals were also re-explored. If any evidence 
of fibrous or neural bridging were encountered, samples of 
tissue were harvested, fixed, and prepared in the above 
manner. 
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G. Miscellaneous Testing 
In animals in which self-mutilation had occurred, the 
number and location of missing toes was reported. Each 
animal's weight was recorded at the time of the initial 
procedure and before sacrificing (Ohaus 2610 Dial-O-Gram 
Balance). At the time of re-exposure of the nerve graft 
segment, each site was graded according to scar tissue 
formation on a scale of one to three indicating: 1) minimal 
scar tissue approximating normal anatomy, 2) moderate 
fibrous proliferation, nerve segment clearly visible, and 
3) heavy fibrous proliferation, nerve graft obscured by 
scar tissue formation. Each animal's score was reported in 
the form of a scar index (see Fig. 13,14). 
H. Statistical Analysis of Data 
Statistical analysis was performed on all experimental 
data utilizing the SAS statistical analysis package on the 
Yale University Computer Center mainframe computer. An 
analysis of variance was conducted among and between the 
three experimental groups by means of Kruskal-Wallis ANOVA 
nonparametric tests. Individual comparisons made between 
the two grafted groups, between operative and nonoperative 
groups and within each group between operative and 
nonoperative legs were tested for probabilities and levels 
of significance by means of the Dunn analysis for multiple 
comparisons using rank sums and with the Student's t-test 
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where appropriate. Linear regression analysis was used to 
analyze the relationship between hydroxyproline 
concentration and tibialis anterior weight and values 
fitted to a general linear model. Estimates for the 
regression parameters of this model were determined. 
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IV RESULTS 
A. Functional Testing 
The results of functional testing support our 
hypothesis that fresh and cryopreserved autografts are not 
statistically different in their ability to affect axonal 
regeneration across the graft segment as evidenced by 
functional recovery but are statistically superior in this 
ability to gap control animals (see Table 1-3). 
Preoperative and postoperative toe spread (TS) (the 
linear distance from the center of the print of the first 
toe to the center of the print of the fifth toe) 
measurements were made and values expressed as a percentage 
of preoperative normal values. Each animal's nonoperative 
leg served as its own control in walking track 
measurements. Significant differences (p < 0.05) existed 
in each group when pre- and postoperative values were 
compared (see Fig. 3). Postoperative values for toe spread 
(a measure of the function of the peroneal nerve branch) 
for the "experimental" side were expressed as a percentage 
of the corresponding value measured for the control side. 
These values were .434 (SD, .011) for the fresh grafted 
group, and .451 (SD, .011) for the cryopreserved grafted 
group. The value for the gap control group was .496 (SD, 
.004). These values do not represent statistically 
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significant differences in return of function between the 
three groups. 
In a further determination of return of function, each 
animal's operative foot was measured for range of motion. 
The normal range of motion for extension at the ankle in 
the rat is 170°. This value was uniformly attained in 
range of motion measurements on nonoperative control feet. 
The mean range of motion in terms of degrees of flexion 
contracture (170° minus the measured motion) in the fresh 
grafted group was 18° (range 30° to 5°) and in the 
cryopreserved grafted group 14° (range 25° 5°). In 
the graft control group, the flexion contracture was 49° 
(range 82° to 28°) (see Fig.4). These values represent 
no statistically significant difference in return of 
function as measured by flexion contracture in the two 
autografted groups. There was, however, a difference 
between the grafted and gap control animals (p < 0.01) 
representing an improvement in functional return in the 
grafted animals (see Fig. 15,16). 
At the time of sacrifice, the rats' tibialis anterior 
muscles were harvested bilaterally and their wet weights 
determined. The tibialis anterior is a long, narrow muscle 
that dorsiflexes the ankle and inverts the foot. It 
received innervation from the deep peroneal nerve, a distal 
branch via the common peroneal nerve of the sciatic nerve. 
In each animal, the nonoperative tibialis anterior muscle 
served as a control for the weight of the muscle on the 
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operative side. There was no statistically significant 
difference between the control tibialis anterior weight 
value among the three groups (see Fig.5). The data did, 
however, represent a statistical difference between 
operative and nonoperative muscle weight within each group 
(p < 0.05) (see Fig.17,18). The mean weight for a tibialis 
anterior muscle innervated via a fresh nerve graft was 
.5877 gm (SD, .0746 gm) and innervated by a cryopreserved 
nerve graft .5801 gm (SD, .0935 gm). Functionally, no 
significant difference is seen between the two grafted 
groups with respect to reinnervation of the tibialis 
anterior muscle as evidenced by the preceding data. 
Functionally the results are superior when the 
reinnervation of the tibialis anterior is compared in the 
grafted groups to the gap controls where the average weight 
of the tibialis anterior was .2089 (SD, .0844) (see Fig.5). 
This difference is significant at the p < 0.01 level. 
B. Sensory Testing 
The results of sensory testing in our experimental 
model were equivocal in their support for our hypothesis 
that sensory return is egual in the fresh and crypreserved 
grafted groups and superior to that in the gap control 
animals. Sensory testing was performed in all rats at two 
week intervals and at the time of sacrifice as described in 
the Methods section. At two weeks, without exception, rats 
had regained some degree of sensibility in the operative 
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foot. The sensory response to painful stimuli was, 
however, always decreased in comparison to the intact 
control foot. Most rats retained this sensibility even 
after the nerve graft segment had been removed. Few rats 
regained minimal sensation to the lateral most toes. No 
rats in the gap control group experienced return of lateral 
toe sensation of any kind. A comparably large number of 
rats in the gap control group showed evidence of self 
mutilation of the lateral toes of the operative foot when 
compared to grafted animals (see Fig.19). 
C. Hydroxyproline Assays 
The results of the hydroxyproline assay confirm our 
hypothesis that fresh and cryopreserved nerve graft 
segments are not statistically different in their ability 
to reinnervate distal musculature but are statistically 
superior in this ability to gap control animals. The whole 
muscle mean intramuscular hydroxyproline content of normal 
tibialis anterior muscle as measured from the nonoperative 
leg of each animal was not statistically different among 
the three groups (see Fig.6). Assays were run on two 
sample concentrations from each tibialis anterior muscle, 
and results were reported as hydroxyproline content in the 
operative leg divided by hydroxyproline content in the 
control leg expressed as a percentage. There were no 
significant differences found in the values obtained by the 
two separate assays within each group. Results showed no 
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statistical difference between the hydroxyproline content 
of tibialis anterior muscle innervated via fresh or frozen 
sciatic nerve grafts (see Fig.7). The mean hydroxyproline 
percentage value in the fresh grafts was 1.382 (SD, .305) 
and 1.527 (SD, .405), and in the cry op reserved grafts 1.655 
(SD, .497) and 1.660 (SD, .456). The results are, however, 
superior when the hydroxyproline level of the tibialis 
anterior was compared in the grafted groups to the gap 
controls where the average hydroxyproline percentage values 
were 4.315 (SD, 1.965) and 4.869 (SD, 2.351)(see Fig.8). 
This difference is significant at the p < 0.01 level. 
D. Histological Studies 
The results of histological analysis confirm our 
hypothesis that no difference exists between the ability of 
fresh and cryopreserved grafts to serve as a conduit for 
axonal regeneration. Fresh and frozen autografts cannot be 
distinguished from one another grossly at the light 
microscopic level with respect to cellular reaction, 
macrophage response, or connective-tissue proliferation. 
Evidence of regeneration was observed at three months in 
all animals receiving a fresh or a frozen graft (see Fig. 
9-12). Electron microscopy demonstrated regenerating fiber 
units and viable Schwann cells in all grafts. Again no 
evidence of cellular infiltrates around the nerve graft was 
seen. No evidence of regeneration or bridging was seen in 
any of the gap control animals. 
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Control values for axonal counts were obtained from the 
sciatic nerve segments removed from the gap control 
animals. Myelinated nerve fiber counts were made and 
neural cross sectional area measured. The mean fiber 
density for the proximal segment was 4,221 (SD, 262), and 
for the distal segment 3,885 (SD, 744). These values do 
not represent a statistical difference. The calculated 
proximal to distal mean fiber density ratio in these 
control nerve segments was .92 (SD, .15) (see Table 3). 
In the animals receiving fresh nerve grafts, the mean 
fiber density calculated as above for the nerve segment 
proximal to the graft was 4,569 (SD, 453) and for the nerve 
graft segment, itself, 5,025 (SD, 457). The calculated 
mean fiber density ratio between the graft and the segment 
proximal to the graft in the animals receiving a fresh 
graft was 1.13 (SD, 0.16) (see Table 1). 
In the animals receiving cryopreserved nerve grafts, 
the mean fiber density for the nerve segment proximal to 
the nerve graft was 4,195 (SD, 728) and for the nerve graft 
segment 5,126 (SD, 297). The calculated mean fiber density 
ratio was 1.26 (SD, 0.30) (see Table 2). There is no 
significant difference between the fresh and cryopreserved 
grafted animals with respect to the number of regenerated 
myelinated nerve fibers within the grafted segments. 
Examination of single fibers regenerating through grafts 
showed that relatively many more fibers of small diameter 
are present in the grafted (fresh or cryopreserved) 
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segments than in the normal nerves (see Fig. 1,2). But 
again no significant difference could be detected with 
respect to axonal number or mean fiber density between 
grafts, either fresh or cryopreserved, and normal nerves. 
E. Hydroxyproline Concentration vs. Wet Weight 
of Tibialis Anterior Muscle 
Linear regression analysis was performed to analyze 
the relationship between hyproxyproline content and wet 
muscle weight of the tibialis anterior muscle at time of 
sacrifice. Comparison values were fitted to a general 
linear model (see graph) and estimates for the regression 
parameters of this model were determined. Statistical 
. p 
analysis of the model revealed an R value of 0.716 and 
an F value of 85.58. These values are significant at the p 
< .0001 level (see Fig.20). 

Ruwe - 74 - 
V. DISCUSSION 
A. Functional Results 
As previously discussed, although easily assessed in 
man, functional recovery is difficult to measure in 
experimental animals. We attempted to quantify functional 
return by adapting the method of deMedinaceli et al. [24], 
devised to evaluate sciatic nerve damage from measurements 
of the hind feet of walking rats, to our experimental 
model. We found their basic assumption that all 
measurements carried equal significance flawed. The most 
reproducible measurement in our series was the toe spread 
measurement (TS). Measurements of paw length (PL) varied 
in response to animal cooperation with the test and proper 
application of developing fluid. In addition, it was 
difficult in paw length measurements to define points of 
reference. In measuring intermediate toe span (IT), most 
points were combined or difficult to resolve. Gutmann [39] 
has shown in his classic article in 1942 that loss of toe 
spread is the most reliable measurement of peroneal nerve 
injury in rabbits. The functional test described by 
deMediceli does work for animals whose nerves are close to 
normal as in the case of a crush injury. This is supported 
by deMedinaceli's data and from unpublished work in our 
laboratory (Trumble et al.). When, however, the normal 
architecture of the nerve is destroyed, the index is less 
reliable. This is supported by our data and, in fact, by 
deMediceli's data in his original report in which the 
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author failed to report follow-up data for the animals with 
repaired transected nerve injuries. 
In the course of functional testing, problems were 
encountered with self mutilation and flexion contractures 
involving the operative foot. These problems were 
converted to statements concerning functional return. The 
animals in the gap control groups consistently engaged in 
higher rates of self mutilation and suffered more severe 
flexion contractures than the grafted animals. Twice as 
many animals, in fact, suffered self mutilation in the gap 
control group when compared to fresh or cryopreserved 
grafted groups. The mean flexion contracture in the gap 
control group was 50° compared with 20° in grafted 
animals. No statistical difference was seen in the 
comparison of the fresh versus the cryopreserved grafts 
with respect to these parameters. 
The wet weight of each animal's tibialis anterior 
muscle was measured at the time of sacrifice. This was 
performed as a test of functionally significant 
reinnervation of distal musculature. Results showed no 
statistical difference between the weights in the fresh and 
cryopreserved grafted animals. Each grafted group was, 
however, statistically superior in terms of results when 
compared to gap control animals. 
A comparison of our results with those of previous 
investigators with respect to functional recovery is 
difficult due to the fact that few have undertaken such 
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determinations. As previously mentioned, many authors 
[21,56,81,94] have used maximum conduction velocities to 
draw functional conclusions from their grafting experiments 
despite the fact that Almguist [4] has proven the lack of 
correlation between clinical results and nerve conduction 
velocity. In light of these findings, we have not 
incorporated nerve conduction velocity measurements into 
our experimental model. 
Hydroxyproline concentrations were determined from the 
rat tibialis anterior muscles of each animal as a further 
test of functional return. Intramuscular hydroxyproline 
levels are known to be a direct indication of collagen 
content. Macdonald [56] et al. have shown, through 
reinnervation studies, a correlation between function and 
collagen content with increasing fibrosis and loss of 
muscle fiber mass indicative of poorer functional 
recovery. We have adapted their methods to our model to 
guantitate functional recovery in terms of hydroxyproline 
concentration. Ours is the first application of this assay 
to nerve grafting experiments. Our results show 
statistically significant differences when expressed as net 
hydroxyproline concentration or when each value of 
hydroxyproline content for the experimental leg is 
expressed as a percentage of the corresponding value 
measured from the control side between grafted and gap 
control animals. In addition, differences are seen between 
grafted and control legs within each group. No 
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stastistically significant difference, however, exists 
between the fresh nerve allografted animals and those 
receiving cryopreserved autografts. 
In conclusion, from our data it was not possible to 
differentiate fresh nerve autografts from cryopreserved 
autografts in terms of functional return with respect to 
direct postoperative measurements, muscle mass or 
hydroxyproline content. Results were, however, superior in 
these two grafted groups to those found in the nongrafted 
gap controls. 
B. Sensory Testing 
Sensory testing is an excellent marker in humans for 
functional return with its return preceding that of motor 
function return. Sensory testing in animals such as the 
rat, however, has proven difficult from a practical 
standpoint and in the interpretation of results. Most if 
not all authors have abandoned sensory function as 
imprecise because of confusing overlapping innervation and 
because measurements of sensory function are usually 
indirect [24,39]. We have through the course of this 
experiment developed what we feel is a reliable, direct, 
and reproducible test for sensory functional return. 
In the course of our sensory testing experiments, we 
found return of sensation within the first week 
postoperatively in all animals in the two grafted groups. 
Even the gap control animals with a 2.0 cm deficit in the 
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sciatic nerve experienced this early return of 
sensibility. At the time of sacrifice, animals retained 
this sensibility even after a 2.0 cm segment of their 
sciatic nerve, i.e. the graft was removed. It was noted, 
however, that the sensibility of the lateral aspect of the 
rat's foot was markedly decreased in the grafted groups and 
totally absent in all cases in the nongrafted gap controls. 
Cajal [17] has shown as a result of his work in 1928 
that return of sensate function involves movement of two 
interacting populations of axons: regenerating fibers from 
the severed nerve and sprouts emitted by intact fibers in 
the skin surrounding the denervated zone. Devor [27] 
through his investigations of these movements behaviorally 
and electrophysiologically showed that the rat's foot 
receives its cutaneous innervation along the saphenous 
nerve (a continuation of the femoral nerve] and the sciatic 
nerve. Through crush and ligation studies, Devor found 
return of sensibility within four days in the sciatic 
distribution due to invasion of branches of the intact 
saphenous nerve. The sciatic nerve, itself, was able to 
reinnervate its distribution of skin twenty days after 
simple injury. When, however, the sciatic nerve was 
ligated, early return of sensation was seen, but sensation 
never returned to the lateral two and a half toes. 
Therefore, it was concluded that this area of the rat's 
foot received innervation solely from the sciatic nerve. 
Sensibility testing in this area can be used as a precise 
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indicator of functional return of regenerated fibers 
through our nerve graft segments in the sciatic nerve. 
Although neither Devor nor subseguent authors anticipated 
its potential application, Devor's work can be used as a 
reliable test for sensory functional return in the rat with 
the return of sensibility to the lateral toe indicating 
return of regenerating axons down the length of the sciatic 
nerve to its terminal branches. Only general conclusions 
can be made as a result of these findings in our current 
study. However, these findings set the stage for further 
use of sensory return to the lateral toes of the rat as a 
quantitative test of functional return in the rat model and 
will be employed in future investigations. 
C. Histology 
In the course of our study, we experienced early 
problems with orientation of peripheral nerve graft segment 
sections secondary to the need to cut segments small enough 
to allow penetration of the glutaraldehyde fixative. These 
problems of only a small practical concern were solved with 
the use of Karnovsky's fixative. This solution has a 
better penetrative capacity and allowed us to fix long 
nerve segments which can be easily oriented to make cross 
sectional cuts. 
Our findings were consistent with those of previous 
investigators including MacKinnon [58,60,61] et al. working 
with fresh isografts and allografts and Singh [95,96,97] 
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working with frozen grafts. What we found was a relative 
increase in the number of myelinated axons of smaller 
diameter in the nerve graft segments when compared to 
proximal segments or normal control axons. Fresh and 
cryopreserved autografts proved equally effective in 
potentiating axonal regeneration with no significant 
differences in either total axonal counts or axonal 
densities found within the two groups. 
The rats' "superlative, regenerative capacity" in 
peripheral nerve injury as described by MacKinnon [128] in 
a recent published report was not seen in our model. None 
of the thirteen rats which received a gap of 2.0 cm in 
their sciatic nerve were able to breech this deficit. In 
fact, little evidence of axonal sprouting was seen at all. 
Biopsy sections were taken in all rats which grossly showed 
any evidence of fibrous spanning and in two rats with no 
evidence of spanning at all. All sections were prepared 
and studied microscopically for presence of neural tissue. 
In these sections, no evidence of neural regeneration was 
seen at either the light or electron microscopic level. 
These findings are consistent with those of Lundberg [54], 
Bucko and Steinmuller [14], and Ducker and Hayes [27] using 
similar experimental models. With our data we may dispute 
MacKinnon's findings on histological grounds and reject the 
notion that gaps of this size can be spontaneously bridged 
by axonal sprouting without a nerve graft or other conduit 
to aid such regeneration. 
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No evidence was seen at the light or electron 
microscopic level of a cellular reaction or macrophage 
response in any of the fresh or cryopreserved grafted nerve 
segments. From these histological findings, we found no 
evidence that freezing an autograft nerve segment under 
optimal conditions and with the use of a cryoprotectant 
agent does in itself alter the grafts' immunogenicity. 
In conclusion, from our data it was not possible to 
differentiate freshly grafted autograft segments from 
cryopreserved autografts by connective tissue 
proliferation, cellular reaction, macrophage response, 
distal myelination, axonal counts, axonal densities, or 
loss of Schwann cells noted on electron microscopy. 
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VI. Conclusion 
Our results have shown through functional tests, 
sensory tests, histological analysis, axonal counts and 
hydroxyproline assays that fresh and cryopreserved 
autografts are egual in their ability to potentiate 
regeneration of axons and return of function in the rat. 
As previously mentioned, these findings have immediate 
clinical applicability in cases of segmental nerve loss in 
a wound not immediately ready for grafting or in a patient 
not yet stabilized for major surgery. If perfected, 
cryopreservation affords the surgeon the ability to perform 
reconstructive surgery in an elective rather than an 
emergent setting. With a method for cryopreserving 
peripheral nerve tissue in place, we can now look at 
isograft and allograft models. The next step is to explore 
the role of immunosuppression in frozen nerve allografts 
with the ultimate goal of developing practical technigues 
for vascularized peripheral nerve allografts. 
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Fig. 1. Axonal densities in the proximal to graft and 
graft portions of the sciatic nerve. Note the increased density 
of regenerating fibers in the graft segments. The Gap bars 
represent normal nerve segments taken from Gap Control animals 
at the time of initial procedure. 
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FIGURE 2. 
Mortal Counts 
Fig. 2. Axonal densities expressed as graft segment 
values as a percentage of proximal to graft control segment 
values in the sciatic nerve. Note the increased axonal density- 
in the grafted animals when compared to control values. 
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FIGURE 3. 
Post—op Toe Spread Measurements 
*3p Ctl Oya Cap 
Fig. 3. Preoperative and postoperative toe spread 
measurements (TS) expressed as a percentage of the control value 
obtained in the non-operative foot. No statistically 
significant difference is seen among the three groups. 
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FIGURE 4. 
Post---Op Flexion Contracture 
Fig. 4. Postoperative flexion contracture measured at the 
time of sacrifice in operative feet. The less severe 
contractures in the grafted groups represent an improvement in 
functional return in the grafted animals. 
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FIGURE 5. 
Ftost— Op Tibialis Anterior Weights 
Fig. 5. Postoperative Tibialis Anterior (TA) weights in 
the operative and nonoperative legs. A significant difference 
is seen when the reinnervation of the TA is compared in the 
grafted groups to the nongrafted Gap Controls as evidenced by 
muscle weights. Again no difference is seen between fresh and 
frozen nerve grafts. 
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FIGURE 6. 
Post—Op Hydroxyproline Concentration 
Fig. 6. Postoperative whole muscle mean intramuscular 
Hydroxyproline (HP) content of normal TA muscle as measured from 
the nonoperative leg. No statistical difference is seen among 
the three groups. 
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FIGURE 7. 
Post-Op Hydroxy proline Concentration 
Hydraxypralina Ratio {frp/Dtl Log} 
Fig. 7. Postoperative whole muscle mean intramuscular 
Hydroxyproline (HP) content of reinervated TA muscle as measured 
from the operative leg. Note the marked increase in HP 
concentration in the nongrafted Gap Animals. No statistical 
difference is seen among the grafted groups. 
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FIGURE 8. 
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Fig. 8. Postoperative HP concentration expressed as a 
percentage of control values obtained from the nonoperative 
leg. Results show no difference in the fresh or frozen grafted 
groups. Results in grafted groups are superior to those in Gap 
Control animals. 
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TABLE 1. Ruwe 91 
Data From Fresh Grafted Group 
Rat Group Grafting End T.A. H HP 1 3s HP 2 3s HP 1 3s HP 2 Function Test 
Leg Weight Weight Weight OP/Ctl OP/Ctl Pre-Op 
(gms) (gms) (gms) (ug/mg) (ug/mg) PL TS IT 
1L Ctl 372.7 511.7 1.0678 1.214 1.169 1.480 1.392 1.65 1.35 1.10 
1R Op Ctl 0.6142 1.797 1.627 1.65 1.90 1.15 
2L Ctl 359.5 506.9 1.0719 1.613 1.518 1.023 1.030 1.85 1.70 1.00 
2R Op Ctl 0.6429 1.650 1.563 1.65 1.70 0.90 
3R Ctl 344.6 473.7 0.9811 1.373 1.345 1.223 1.312 1.10 1.80 1.00 
3L Op Ctl 0.5274 1.679 1.765 1.10 1.70 1.10 
4R Ctl 311.5 478.5 0.9893 1.321 1.208 1.134 1.300 1.50 1.80 1.00 
4L Op Ctl 0.5298 1.499 1.590 1.50 1.70 1.10 
5L Ctl 333.5 483.5 0.9965 1.768 1.742 1.094 1.197 1.50 1.80 1.10 
5R Op Ctl 0.6196 1.934 2.086 1.60 1.90 1.10 
6L Ctl 318.8 435.6 0.9176 1.013 0.985 1.819 2.010 1.80 1.80 1.20 
6R Op Ctl 0.5944 1.843 1.980 1.60 1.70 1.10 
7L Ctl 320.0 570.3 1.1087 1.186 1.102 1.221 1.386 1.65 1.55 0.90 
7R Op Ctl 0.7412 1.449 1.527 1.65 1.65 1.10 
8L Ctl 317.6 450.0 0.8872 1.214 1.206 1.322 1.363 1.70 1.85 1.10 
8R Op Ctl 0.5147 1.606 1.644 1.75 1.90 1.10 
9R Ctl 334.5 587.1 1.1299 0.601 0.550 2.004 2.441 1.70 1.70 1.00 
9L Op Ctl 0.4855 1.205 1.342 1.60 1.70 0.95 
10L Ctl 313.7 500.7 1.0391 1.034 0.950 1.377 1.705 1.65 1.70 0.85 
10R Op Ctl 0.5514 1.423 1.621 1.65 1.75 0.90 
11R Ctl 314.0 500.9 1.0105 1.000 0.981 1.500 1.665 1.60 1.55 0.85 
11L Op Ctl 0.6440 1.500 1.634 1.60 1.60 1.00 
MEAN 330.9 499.9 CTL 1.0181 1.212 1.160 1.382 1.527 
OP 0.5877 1.599 1.671 
STD DEVIATION 0.0751 0.316 0.314 0.305 0.405 
0.0746 0.212 0.207 
VARIANCE 0.0056 0.100 0.099 0.093 0.164 
0.0056 0.045 0.043 
STD ERROR OF MEAN 0.0227 0.095 0.095 0.092 0.122 
0.0225 0.064 0.063 
LEGEND 
TA = Tibialis Anterior TS = Toe Spread (mm) 
HP = Hydroxyproline IT = Intermediary Toe Spread (mm) 
PL = Paw Length (mm) A-Op TS = Pre-Op Toe Spread 
A-Op Ts 
Op/Ctl 
1.027 
1.000 
0.944 
0.944 
1.056 
0.944 
1.065 
1.027 
1.000 
1.029 
1.032 
1.006 
0.002 
0.000 
0.001 
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Function Test P-Op TS Toes Flex PG PG Graft Graft PG Axons Gft Axons Gft/PG 
Post-Op Op/Ctl Missing Contr Ax Ct Area Ax Cts Area mm*2 mm'2 Axon f 
PL TS IT (dgs) (rnm‘2) (mm*2) 
1.65 1.85 1.20 0.459 
1.60 0.85 0.80 intact 7894 1.5868 3,816 0.9034 4,974.79 4,224.22 0.85 
2.10 2.10 
2.20 0.40 
1.20 0.190 
f 4,5 140 8934 2.0205 7,265 1.4156 4,421.68 5,132.24 1.16 
2.00 2.00 
2.90 1.10 
0.90 0.549 
intact 150 3,494 0.8046 4,342.36 
1.75 1.65 1.25 0.424 
2.30 0.70 0.60 intact 140 8881 1.9560 3,735 0.7334 4,540.29 5,092.66 1.12 
1.90 1.90 
2.90 1.00 
1.00 0.526 
intact 8577 1.8104 5,037 0.9244 4,737.63 5,448.80 1.15 
2.30 2.10 1.10 0.429 
2.10 0.90 0.90 intact 6628 1.6298 4,743 0.3643 4,066.74 5,487.68 1.35 
2.00 2.10 
2.50 1.10 
1.10 0.524 
t 3,4,5 165 6730 1.8941 4,301 0.8786 3,553.21 4,895.34 1.38 
2.00 2.00 
2.90 0.90 
1.10 0.450 
intact 165 9526 1.9149 4,289 0.7872 4,974.76 5,443.47 1.10 
2.30 1.90 
2.80 0.80 
1.10 0.420 
intact 145 8620 1.7664 4,496 0.8313 4,879.98 5,408.51 1.11 
2.40 1.90 1.00 0.369 
3.00 0.70 
2.00 1.75 1.10 
intact 155 10644 2.2141 7,311 1.5963 4,807.46 4,580.06 0.95 
3.10 f 3,4,5 150 8596 1.8143 7,791 1.4949 4,737.80 5,211.57 1.10 
0.434 151 7,730 1.8607 5,116 1.0213 4,569.44 5,024.72 1.13 
F-Op TS = Postoperative Toe Spread 
PG = Proximal to Graft 
Gft = Graft 
Ax Ct = Axonal Counts 

TABLE 2. 
Data From Cryopreserved Grafted Group 
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Rat Group Grafting End T.A. 3s HP 1 3s HP 2 3s HP 1 3s HP 2 Function Test A-Op Ts 
Leg Weight Weight Weight OP/Ctl OP/Ctl Pre-Cp Op/Ctl 
(gms) (gms) (gms) (ug/mg) (ug/mg) PL TS IT 
1R Cry 293.3 383.5 0.7833 1.391 1.334 1.000 0.998 1.65 1.60 1.15 1.094 
1L Op Cry 0.4270 1.391 1.331 1.50 1.75 1.00 
2R Cry 293.9 532.7 1.1473 1.037 1.093 1.328 1.735 1.70 1.70 1.00 1.000 
2L Op Cry 0.6491 1.896 1.896 1.70 1.70 0.90 
3L Cry 292.1 494.2 1.0568 0.844 0.846 1.885 1.979 1.60 1.30 1.00 0.944 
3R Op Cry 0.5804 1.591 1.675 1.60 1.70 1.10 
4R Cry 303.3 520.5 1.0123 1.185 1.220 1.289 1.262 1.60 1.90 1.00 0.947 
4L Op Cry 0.7047 1.527 1.540 1.60 1.80 0.95 
5L Cry 316.5 505.9 1.2187 0.916 0.365 1.418 1.693 1.60 1.70 1.10 1.000 
5R Op Cry 0.5829 1.299 1.464 1.60 1.70 1.10 
6R Cry 310.5 514.9 1.1434 0.769 0.824 2.360 2.533 1.60 1.85 1.00 1.027 
6L Op Cry 0.6374 1.815 2.087 1.50 1.90 0.90 
7L Cry 343.8 598.2 1.2901 0.984 0.891 1.255 1.481 1.55 1.90 1.05 1.000 
7R Op Cry 0.4222 1.234 1.391 1.55 1.90 1.00 
8L Cry 321.4 535.7 1.0366 0.902 0.942 1.131 1.118 1.55 2.00 1.10 0.900 
8R Op Cry 0.6092 1.020 1.119 1.70 1.80 1.00 
9L Cry 350.6 517.1 1.0536 0.728 0.856 2.494 2.155 1.70 2.00 0.95 0.950 
SR Op Cry 0.7164 1.815 1.845 1.60 1.90 1.05 
10L Cry 317.5 470.0 0.9330 1.426 1.503 1.293 1.263 1.55 1.80 0.95 0.861 
10R Op Cry 0.5205 1.845 1.398 1.60 1.55 1.00 
11L Cry 327.1 492.1 0.8226 1.096 1.181 1.765 1.751 1.60 1.90 1.25 0.974 
hr Op Cry 0.5503 1.935 2.068 1.65 1.85 1.00 
12R Cry 350.0 501.4 0.9417 0.966 1.114 2.140 1.956 1.60 1.90 0.90 1.000 
12L Op Cry 0.5610 2.068 2.179 1.60 1.90 1.00 
MEAN 319.2 505.5 CTL 1.0366 1.020 1.056 1.655 1.660 0.975 
OP 0.5801 1.620 1.703 
STD DEVIATION 0.1514 0.222 0.221 0.497 0.456 0.004 
0.0935 0.327 0.339 
VARIANCE 0.0229 0.049 0.049 0.000 
0.0087 0.107 0.115 
STD ERROR OF KEAN 0.0437 0.064 0.064 0.143 0.132 0.001 
0.0270 0.094 0.098 
LEGEND 
TS = Toe Spread (mm) 
IT = Intermediary Toe Spread (mm) 
A-Op TS = Pre-Op Toe Spread 
TA = Tibialis Anterior 
HP = Hydroxyproline 
PL = Paw Length (am) 

TABLE 2. (cent.) Ruwe 94 
Function Test P-Qp TS Toes Flex PG PG Graft Graft PG Axons Gft Axons Gft/PG 
Post-Op Op/Ctl Kissing Contr Ax Ct Area Ax Cts Area m'2 m*2 Axon # 
PL TS IT (dgs) (mm'2) (m'2) 
2.00 1.90 1.00 0.474 
3.00 0.90 0.90 intact 160 6456 1.7970 5,042 0.9188 3,592.65 5,487.59 1.53 
2.20 2.10 
3.50 0.70 
1.00 0.333 
1 3,4,5 165 11254 2.7147 5,276 1.1230 4,145.56 4,698.24 1.13 
2.10 2.10 
2.80 0.90 
1.20 0.429 
intact 160 9088 1.7308 8,781 1.7110 5,250.82 5,132.23 0.98 
2.10 2.10 
2.80 0.70 
1.20 0.333 
f 4,5 165 6703 1.5337 4,264 0.8925 4,370.62 4,777.46 1.09 
2.20 2.00 
3.00 0.90 
1.20 0.450 
intact 160 6896 1.5879 5,368 1.1053 4,342.90 4,856.50 1.12 
2.00 2.10 
3.50 0.90 
0.90 0.429 
intact 165 2985 0.6462 3,898 0.7155 4,619.31 5,447.89 1.18 
1.90 1.90 
2.90 1.00 
1.10 0.526 
intact 145 9384 2.2009 5,340 1.0246 4,263.79 5,211.71 1.22 
2.20 2.00 
2.80 1.30 
1.00 0.650 
intact 160 9466 2.2360 3,931 0.7601 4,233.44 5,171.69 1.22 
2.00 2.00 
2.70 1.10 
1.00 0.550 
# 4,5 160 6760 1.3273 5,837 1.0868 5,092.97 5,370.62 1.05 
1.90 2.10 
2.50 0.60 
1.10 0.286 
#1,2,4,5 145 6106 1.3686 6,000 1.1873 4,461.37 5,053.35 1.13 
intact 160 8020 3.0779 4,831 1.0112 2,605.69 4,777.39 1.83 
1.90 2.00 
2.90 1.00 
1.10 0.500 
intact 145 6152 1.8332 5,957 1.0777 3,355.88 5,527.51 1.65 
0.451 157.5 7,439 1.8378 5,377 1.0512 4,194.58 5,126.01 1.26 
P-Op TS = Postoperative Toe Spread 
PG = Proximal to Graft 
Gft = Graft 
Ax Ct = Axonal Counts 

TABLE 3. 
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Data From Nongrafted Gap Control Group 
Rat Group Grafting End T.A. k HP 1 k HP 2 % HP 1 % HP 2 Function Test 
Leg Weight Weight Weight OP/Ctl OP/Cti Pre-Op 
m m m m m * * m 
(gms! (gms) (gms! (ug/mg) (ug/mg) PL TS IT 
1R Gap 313.2 521.8 1.1260 0.860 0.829 2.229 2.375 1.60 1.55 0.90 1.065 
1L Op Gap 0.4328 1.916 1.832 1.50 1.65 0.95 
2L Gap 352.2 469.8 0.9424 0.948 0.808 7.888 9.462 1.85 1.90 0.80 0.842 
2R Op Gap 0.1359 7.475 7.648 1.50 1.60 0.85 
3R Gap 377.1 512.6 1.1617 1.298 1.227 2.030 2.358 1.60 1.70 1.15 1.059 
3L Op Gap 0.2409 2.635 2.894 1.50 1.80 1.05 
4L Gap 412.4 539.3 1.1113 1.678 1.613 1.448 1.585 1.60 1.95 1.30 0.923 
4R Op Gap 0.3070 2.430 2.556 1.50 1.80 1.20 
5R Gap 384.2 470.0 1.0318 1.259 1.151 3.947 4.423 1.55 2.00 1.10 0.925 
5L Op Gap 0.1538 4.967 5.090 1.55 1.85 1.10 
6L Gap 404.5 526.0 1.1553 1.679 1.549 2.862 3.101 1.40 1.65 1.00 1.000 
6R Op Gap 0.2070 4.804 4.804 1.40 1.65 1.05 
7R Gap 336.9 525.8 1.0810 1.080 0.979 6.568 3.061 1.45 1.75 0.90 1.029 
7L Op Gap 0.1181 7.091 7.888 1.30 1.80 1.10 
8L Gap 327.4 470.5 0.9344 1.333 1.172 5.993 6.843 1.40 1.75 1.10 0.971 
8R Op Gap 0.1872 7.991 8.018 1.45 1.70 0.95 
9R Gap 317.4 503.9 1.0753 1.215 1.047 3.934 4.686 1.60 1.80 1.10 1.056 
9L Op Gap 0.1610 4.780 4.905 1.60 1.90 1.15 
10L Gap 323.0 416.9 0.8752 1.145 1.053 4.931 5.503 1.45 1.35 1.15 0.973 
10R Op Gap 0.2032 5.645 5.795 1.30 1.80 0.90 
11L Gap 324.1 531.5 1.0478 1.476 1.427 4.6Q5 4.781 1.40 1.80 0.95 0.861 
hr Op Gap 0.2241 6.795 6.821 1.30 1.55 0.95 
12L Gap 313.0 548.8 1.1411 1.695 1.676 3.329 3.651 1.45 1.75 0.95 0.971 
12R Op Gap 0.2072 5.644 6.119 1.55 1.70 1.10 
13L Gap 319.0 475.3 1.0249 1.429 1.416 6.328 6.471 1.60 1.70 0.90 1.029 
13R Op Gap 0.1372 9.040 9.161 1.55 1.75 0.95 
MEAN 346.9 501.0 CTL 1.0545 1.315 1.227 4.315 4.869 0.977 
OP 0.2089 5.478 5.656 
STD DEVIATION 0.0909 0.272 0.288 1.965 2.351 0.005 
0.0844 2.211 2.271 
VARIANCE 0.0083 0.074 0.083 0.000 
0.0071 4.887 5.156 
STD ERROR OF MEAN 0.0252 0.075 0.080 0.545 0.652 0.001 
0.0234 0.613 0.630 
LEGEND 
TA = Tibialis Anterior TS = Toe Spread (mm) 
HP = Hydroxyproline 
PL = Paw Length (mm) 
IT = Intermediary Tee Spread 
A-Qp TS = Pre-Op Toe Spread 

TABLE 3. (cent.) Ruwe 96 
Function Test P-Op TS Toes Flex Prox Prcx Distal Distil Prox Ax Dist Ax P/D 
Post-Op Op/Ctl Missing Contr Ax Ct Area Ax Cts Area am* 2 mm'2 Axon f 
PL TS IT (dgs) (mm'2) (ma‘2) 
2.20 1.80 1.10 0.500 
3.10 0.90 f 3,4,5 130 7113 1.6530 6,463 1.5892 4,303.18 4,066.79 0.95 
2.10 1.90 1.00 0.579 
3.00 1.10 intact 135 
2.10 2.10 1.10 0.476 
3.30 1.00 intact 130 
2.10 2.00 1.10 0.450 
3.10 0.90 intact 140 6643 1.6978 5,620 1.5643 3,912.76 3,592.60 0.92 
2.10 2.10 1.10 0.429 
3.10 0.90 intact 120 7645 1.7603 4,871 1.1421 4,343.09 4,265.06 0.98 
1.90 2.10 1.20 0.476 
3.10 1.00 intact 125 5370 1.2834 1,574 0.7247 4,184.20 2,172.02 0.52 
2.00 2.00 1.20 0.400 
3.00 0.80 I 4,5 90 7972 1.6418 7,583 1.5238 4,855.59 4,976.36 1.02 
2.20 1.80 1.00 0.500 
3.50 0.90 f 4,5 110 6047 1.4863 7,982 1.8095 4,068.50 4,411.25 1.08 
2.00 1.80 1.00 0.444 
2.30 0.80 I 4,5 88 6649 1.6512 6,679 1.7981 4,026.75 3,714.47 0.92 
1.90 2.00 1.20 0.500 
3.30 1.00 intact 130 7137 1.6434 5,285 1.2282 4,342.81 4,303.08 0.99 
1.90 1.90 1.10 0.526 
2.90 1.00 f 3,4,5 125 5917 1.4272 5,615 1.4815 4,145.76 3,790.09 0.91 
2.40 1.80 1.10 0.555 
3.30 1.00 intact 142 5413 1.3712 5,221 1.4692 3,947.71 3,553.56 0.90 
1.80 1.80 0.90 0.611 
3.20 1.10 # 4,5 110 5103 1.1855 4,304.22 
0.496 121.2 6,455 1.5274 5,689 1.4331 4,221.32 3,884.53 0.92 
P-Op TS = Postoperative Toe Spread 
PG = Proximal to Graft 
Gft = Graft 
Ax Ct = Axonal Counts 
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FIGURE 9. Cross sectional photomicrograph of the proximal 
to graft region of the sciatic nerve of a cryopreserved nerve 
grafted rat taken three months after grafting. 
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FIGURE 10. Cross sectional photomicrograph of a normal 
sciatic nerve taken from a gap control animal (#10) in the 
region where sections were obtained in grafted sciatic nerve 
segments. 
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FIGURE 11. Cross sectional photomicrograph of a fresh 
grafted sciatic nerve taken three months after grafting in the 
same region as the control pictured in Figure 10. A population 
of well myelinated nerve fibers is noted. 
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FIGURE 12. Cross sectional photomicrograph of a 
cryopreserved grafted sciatic nerve taken three months after 
grafting in the same region as the control pictured in Figure 
10. A population of well myelinated nerve fibers is noted as in 
Figure 11. 
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FIGURE 13. Initial re-exploration three months after 
implantation of a fresh nerve autograft. Note the minimal 
fibrotic proliferation which allowed easy harvest of the nerve 
graft segment. 
Figure 14. A 2.0 cm sciatic nerve cropreserved autograft 
(marked by pins) three months aftter inplantation. Again note 
the minimal fibrosis. 
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FIGURES 15,16 An example of a gap control rat three 
months after the initial procedure. Note the marked atrophy in 
the operative left leg. This animal had a measured flexion 
contracture of 40 degrees. Atrophy and flexion contractures of 
this magnitude were not seen in the fresh or cryopreserved 
grafted animals. 
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FIGURES 17,18. Tibialis anterior (above) and extensor 
digitorum longus (below) muscles in the operative (Figure 16) 
and nonoperative (Figure 17) legs of a rat from the gap control 
group. Note the marked decrease in muscle mass in the operative 
leg. 
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FIGURE 19. Self mutilation seen most frequently in the 
operative feet of gap control animals. This animal has lost its 
lateral three toes. 
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FIGURE. 20. 
Fig. 20. Linear regression model of the relationship 
between Hydroxyproline concentration and wet Tibialis Anterior 
muscle weight at the time of sacrifice. 



Ruwe 106 
BIBLIOGRAPHY 
1. Aguayo AJ, Attiwell M, Trecarten J, Perkins S, Bray GM: 
Abnormal myelination in transplanted trembler mouse Schwann 
cells. Nature 265: 73-75, 1977. 
2. Aguayo AJ, Kasarjian J, Skamene E, Kongshaun P, Bray GM: 
Myelination of mouse axons by Schwann cells transplanted from 
normal and abnormal human nerves. Nature 268: 753-755, 1977. 
3. Albert E: Nerve Transplantation. Weiner Med. Presse 26: 
1285, 1885. 
4. Almquist E, EEG-Olofsson O: Sensory-nerve-conduction 
velocity and two-point discrimination in sutured nerves. J 
Bone Joint Surg 52A: 791-796, 1970. 
5. Armstrong JA, Farrant J, Walter CA: Prevention of damage to 
organized tissue during freezing and thawing. Cryobiology 2: 
301-312, 1966. 
6. Askanas V, Engel WK, Dalakas MC, Lawrence JV, Carter LS: 
Human Schwann cells in tissue culture: Histochemical and 
ultrastructural studies. Arch Neurol 37: 329-337, 1980. 
7. Ballance C, Duel AB: The operative treatment of facial palsy 
by the introduction of nerve grafts into the fallopian canal 
and by other intratemporal methods. Arch. Otolaryng 

Ruwe 107 
8. Banks RW, Barker D, Brown HG: Sensory reinnervation of 
muscles following nerve section and suture in cats. J Hand 
Surg 10-B: 340-344, 1985. 
9. Becker CM, Gueuning CO, Graff GL: Sutures or fibrin glue for 
divided rat nerves: Schwann cell and muscle metabolism. 
Microsurgery 6: 1-10, 1985. 
10. Bently FH, Hill M: Possibilities of nerve grafting. Brit. 
Med. J. 2: 352, 1940. 
11. Berger A, Millesi H: Nerve Grafting. Clin Orthop 133: 
49-55,1978. 
12. Bray GM, Rasminsky M, Aguayo AJ: Interactions between axons 
and their sheath cells. Ann Rev Neurosci 4: 127-162, 1981. 
13. Buch VI: Experimental study of radiated vs. fresh nerve 
homografts. Plast Reconstr Surg 45: 586-593, 1970. 
14. Bucko CD, Steinmuller D: Reinnervation after orthotopic 
grafting of peripheral nerve segments in inbred rats. Plast 
Reconstr Surg 53: 326-331, 1974. 
15. Bunnell S, Boyes JH: Nerve Grafts. Am J Surg 44: 64-75, 
1939. 

Ruwe 108 
16. Cabaud HE, Rodkey WG, Nemeth TJ: Progressive ulna structural 
changes after peripheral nerve transection and repair. J 
Hand Surg 7: 353-365, 1982. 
17. Cajal RY: Degeneration and Regeneration of the Nervous 
System. Oxford Press, Oxford Eng. 1928. 
18. Chung PKC, Chung SKY: Evaluation of Imuran and Cockes 
solution in peripheral nerve homografts. Exp Neurology 42: 
141-145, 1974. 
19. Comtet JJ, Revilland JP: Peripheral nerve allograft; 
distinctive histological features of nerve degeneration and 
immunological rejection. Transplantation 28: 103-106, 1979. 
20. Das GD, Houle JD, Brasko J, Das KG: Freezing of neural 
tissues and their transplantation in the brain of rats: 
Technical details and histological observations. J Neurosci 
Methods 8: 1-15, 1983. 
21. deMedinaceli L, Church AC, Wang Y: Post-traumatic autoimmune 
reaction in peripheral nerve: Effect of a single injury. 
Exp Neurol 88: 372-84, 1985. 
22. deMedinaceli L, Church AL, Wang Y: Post-traumatic autoimmune 
reaction in peripheral nerve: effect of two successive 
injuries at the same site. Exp Neurol 88: 385-395, 1985. 

Ruwe 109 
23. deMedinaceli L, Freed WJ: Peripheral nerve reconnection: 
immediate histological consequences of distributed mechanical 
support. Exp Neuro 81: 459-468, 1983. 
24. deMedinaceli L, Freed WJ, Wyatt RJ: An index of the 
functional condition of rat sciatic nerve based on 
measurements made from walking tracks. Exp Neurology 77: 
634-643, 1982. 
25. deMedinaceli L, Freed WJ, Wyatt RJ: Peripheral nerve 
reconnection improvement of long-term functional effects 
under simulated clinical conditions in the rat. Exp Neuro 
81: 488-496, 1983. 
26. deMedinaceli L, Wyatt RJ, Freed WJ: Peripheral nerve 
reconnection: mechanical, thermal, and ionic conditions that 
promote the return of function. Exp Neuro 81: 469-487, 1983. 
27. Devon M, Schonfeld D, Seltzer Z, Wall PD: Two modes of 
cutaneous reinnervation following peripheral nerve injury. J 
Comp Neur 185: 211-220, 1979. 
28. Doebbler GG: Cryoprotective compounds, review and discussion 
of structure and function. Cryobiology 3: 2-11, 1966. 
29. Ducker TB, Hayes GJ: Peripheral nerve grafts: experimental 
studies in the dog and chimpanzee to define homograft 
limitations. J Neurosurg 32: 236-243, 1970. 

Ruwe 110 
30. Duel AB: History and development of the surgical treatment 
of facial palsy. Surg Gynaec Obstet 56: 382, 1933. 
31. Eden R: Die freie transplantation der peripheren neruen sum 
ersats von neruendefeken. Arch J klin Chir 112: 471-512, 
1919. 
32. Farrant J: Mechanism of cell damage during freezing and 
thawing and its prevention. Nature 205: 1284-1287, 1966. 
33. Farrant J, Walter CA, Heather L, McGann LE: Use of two step 
cooling procedure to examine factors influencing cell 
survival and growth following freezing and thawing. 
Cryobiology 14: 273-286, 1977. 
34. Freed WJ, deMedinaceli L, Wyatt RJ: Promoting functional 
plasticity in the damaged nervous system. Science 227: 
1544-1552, 1985. 
35. Foerster 0: Handbuch der Neuroloqie. Teil II, Abs. 3 Benun, 
1929. 
36. Gordon L, Bunckle H, Jewett DL, Muldowney B, Bunckle G: 
Predegenerated nerve autografts as compared with fresh nerve 
autografts in freshly cut and precut motor nerve defects in 
the rat. J Hand Surg 4: 42-47, 1979. 

Ruwe 111 
37. Grab WC: Primary and secondary nerve repair. Letter to the 
editor, Plast Reconstr Surg 70: 275-276, 1982. 
38. Greer CA, Mori K, Shepherd GM: Localization of synapal 
responses in the in vitro turtle olfactory bulb using the 
[14C] 2-deoxyglocose method. Brain Research 217: 295-303, 
1981. 
39. Gutman E, Sanders FK: Functional recovery following nerve 
grafts and other types of nerve bridge. Brain 65: 373-407, 
1942. 
40. Hirasawa Y, Inoue A: Experimental and clinical study on 
peripheral nerve allografting. Neurol Med Chir(Tokyo) 21: 
101-110, 1981. 
41. Huber GC: A study of the operative treatment for loss of 
nerve substance in peripheral nerves. J Morphol 11: 629-740, 
1895. 
42. Huber GC: Transplantation of peripheral nerves. Arch Neurol 
Psychiatry, 2: 466-481, 1919. 
43. Huber GC: Repair of peripheral nerve injuries. Surg Gynec 
Obstet. 30: 464-471, 1920. 
44. IHM PA, Samii M: Quantitative study of muscle fibre atrophy 
and restitution after nerve grafts. Acta Neurochir 34: 

Ruwe 112 
45. Jabaley ME, Wallace WH, Heckler FR: Internal topography of 
major nerves of the forearm and hand: A current view. J 
Hand Surg 5: 1-18, 1980. 
46. Kabow AM: Cryopreservation: Biophysical and chemical 
considerations. In A.M. Karow, GJM Abouna, and AL Humphries 
(eds.), Organ Preservation for Transplantation, Little 
Brown, Boston, pp 51-86, 1974. 
47. Karow AM, Carrier O, Holland WC: Toxicity of high dimethyl 
sulfoxide concentrations in rat heart freezing. Cryobiology 
3: 464-468, 1967. 
48. Keunen RWM, Slooff ACJ: Sensibility testing after nerve 
grafting. Clin Neurol Neurosurg 85: 93-99, 1983. 
49. Kilvington B: An investigation of the regeneration of nerves 
with regard to surgical treatment of certain paralysis. Brit 
Med J. 1: 1414, 1908. 
50. Kline DG, Hayes GJ, Morse AS: A comparative study of 
response of species to peripheral nerve injuries. J 
Neurosurg 21: 980-988, 1964. 
51. Kolata G: Cell surgery to reconnect nerves. Science 221: 
538-539, 1983. 

Ruwe 113 
52. Lenz H, Goentz W, Proessler H, Noack W: The freezing 
threshold of peripheral motor nerves following pretreatment 
with dimethyl sulfoxide and ethanol: an electro-physiologic 
and light and electron microscopic study on the sciatic nerve 
of rabbits. Cryobiology 14:215-227, 1977. 
53. Levinthal R, Brown WJ, Rand RW: Fasicular nerve allograft 
evaluation. Part 1: comparison with autografts by light 
microscopy. J Neurosurg 48: 423-427, 1978. 
54. Lundburg G, Dahlin LB, Danielsen N, Hansson HA, Johannesson 
A, Longo FM, Varon S: Nerve regeneration across an extended 
gap: a neurobiological view of nerve repair and the possible 
involvement of neuronotropic factors. J Hand Surg 7: 
580-587, 1982. 
55. Lundburg G, Hansson HA: Nerve regeneration through preformed 
pseuosynovial tubes. J Hand Surg 5: 35-38, 1980. 
56. MacDonald BM, Bolesta MJ, Seaber AV, Garrett WE: 
Hydroxyproline quantitation in normal muscle and denervated 
muscle after immediate and delayed nerve repair. Trans 32 
ORS 11: 186, 1986. 
57. Mackinnon SE, Hudson AR, Bilbao J, Kline D, Hunter D: Nerve 
allograft response: A quantitative immunological study. 
Neurosurgery 10: 61-84, 1982. 

Ruwe 114 
58. Mackinnon SE, Hudson AR, Falk RE, Kline D, Hunter D: 
Peripheral nerve allograft: an assessment of regeneration 
across pretreated nerve allografts. Neurosurgery 15: 
690-693, 1984. 
59. Mackinnon SE, Hudson AR, Falk RE, Kline D, Hunter D: 
Peripheral nerve allograft: an immunological assessment of 
pretreatment methods. Neurosurg 14: 167-171, 1984. 
60. Mackinnon SE, Hudson AR, Falk RE, Hunter DA: The nerve 
allograft response an experimental model in the rat. Annals 
of Plastic Surg 14: 334-339, 1985. 
61. Mackinnon SE, Hudson AR, Hunter DA, Trued S: Nerve 
regeneration in the rat model. Peripheral Nerve Repair 
Regeneration 1: 41-48, 1986. 
62. Malinin TI, Wagner JL, Pita JC, Lo H: Hypothermic storage 
and cryopreservation of cartilage. Clin Orthop 197: 15-26, 
1985. 
63. Mankin HJ, Fogelson FS, Thrasher AZ et al: Massive resection 
and allograft transplantation in the treatment of malignant 
bone tumors. N Engl J Med 294: 1247, 1976. 
64. Marmor L: Regeneration of peripheral nerves by irradiated 
homografts. J Bone and Joint Surg 46A: 383-394, 1964. 

Ruwe 115 
65. Marmor L, Miner R, Foster J: Experimental prevention of 
nerve homograft rejection by use of immunosuppressive drugs 
J Neurosurg 27: 415-418, 1967. 
66. Mayo-Robson AW: Nerve grafting as a means of restoring 
function in limbs paralysed by gunshot on other injuries. 
Brit Med J 1: 117-118, 1917. 
67. McFarlane RM, Mayer JR: Digital nerve grafts with the 
lateral antebrachial cutaneous nerve. J Hand Surg 3: 167-73 
1976. 
68. Millesi H: Discussion: The use of fresh or preserved 
allografts. In Gorio A, Millesi H, Mingrino S (eds): 
Posttraumatic peripheral nerve regeneration: Experimental 
basis and clinical implications. New York, Raven Press, 
1981. 
69. Millesi H: Nerve grafting symposium on peripheral nerve 
microsurgery, Clinics in Plastic Surg 11: 105-113, 1984. 
70. Millesi H, Meissl G, Berger A: Further experience with 
interfascicular grafting of the median, ulnar, and radial 
nerves. J Bone Joint Surg 58A: 209-218, 1976. 

Ruwe 116 
71. Millisi H, Meissl G, Berger A: The interfasicular 
nerve-grafting of the median and ulnar nerves. J Bone Joint 
Surg 54A: 727-750, 1972. 
72. Moretto G, Kim SU, Shin DU, Pleasure DE, Rizzuno N: Long 
term cultures of human adult Schwann cells isolated from 
autopsy materials. Acta Neuropathol (Berl) 64: 15-21, 1984. 
73. Neuman RE, Logan MA: The determination of hydroxyproline. J 
Biol Chem 184: 299-306, 1950. 
74. Palm J, Black G: Interrelationships of inbred rat strains 
with respect to Ag-B and Non Ag-B antigens. Transplantaton 
11: 184-189. 
75. Parekh PK: Homologous nerve transplantation and 
immunosuppression in rabbits. Res Exp Med 179: 121-131, 
1981. 
76. Parrish FF: Allograft replacement of all or part of the end 
of a long bone following exision of a tumor. J Bone Joint 
Surg 55A: 1, 1973. 
77. Peyronnard JM, Charron L: Muscle reorganization after 
partial denervation and reinnervation. Muscle & Nerve 3: 
509-518, 1980. 

Ruwe 117 
78. Philipeaux JM, Vulpian A: Note Sur des essais de greffe d'un 
troncon de herf lingual entre deux bouts du nerf hypoglosse 
apres excision d'un segment de ce dernier nerf. Arch de 
Physiol Norm et. Pathol 3: 618-620, 1870. 
79. Piepmeier JM, Kauer JS, Greer CA: Caminal distributions of 
z-deoxyglucose uptake in the rat spinal cord following 
electrical stimulation of the sciatic nerve. Brain Research 
259: 167-171, 1982. 
80. Pollard JD, Fitzpatrick L: An ultrastructural comparison of 
peripheral nerve allografts and autografts. Acta Neuropath 
23: 152-165, 1973. 
81. Pollard JD, McLeod JG: Fresh and predegenerate nerve 
allografts and isografts in trembler mice. Muscle & Nerve 4 
274-281, 1981. 
82. Pollard JD, McLeod JG: Nerve grafts in the trembler mouse: 
An electrophysiolgical and histological study. J Neurol Sci 
46: 373-383, 1980. 
83. Pollard JD, McLeod JG, Gye RS: Regeneration through 
peripheral nerve allografts: An electrophysiological and 
histological study following the use of immunosuppressive 
therapy. Arch Neurol 28: 31-37, 1973. 

Ruwe 118 
84. Porat S, Nyska M, Sofer B, Shoshan S: Increased 
collagenolytic activity in severed and sutured tendons 
following topical application of exogenous collagen in 
chickens. J Ortho Res 3: 43-48, 1985. 
85. Restrepo Y, Merle M, Michon J, Folliguet B, Barrat E: Free 
muscularized nerve grafts: An experimental study in the 
rabbit. Microsurgery 6: 78-84, 1985. 
86. Richardson PM, McGuiness UM, Aguyao AJ: Peripheral nerve 
autografts to the rat spinal cord: studies with axonal 
tracing methods. Brain Res 237: 147-162, 1982. 
87. Roufa D, Bunce MB, Johnson ML, Cornbrooks CJ: Variation in 
content and function of non-neuronal cells in the outgrowth 
of sympathetic ganglia from embryos of differing ages. J 
Neuroscience G: 790-802, 1986. 
88. Salafsky B: Functional studies of regenerated muscles from 
normal and dystrophic mice. Nature 229: 270-272, 1971. 
89. Samii M, Scheinpflug W: Klinishe, Elertro-myographische und 
quantitativ histologische untersuchungen nach 
nerven-transplantation. Acta Neurochir 30: 1-29, 1974. 
90. Sanders FK, Young JZ: The degeneration of re-innervation of 
grafted nerves. J Anat 76: 143-166, 1941. 

Ruwe 119 
91. Schroder JM: Altered ratio between axon diameter and myelin 
sheath thickness in regenerated nerve fibers. Brain Res 45: 
49-65, 1972. 
92. Seddon HJ: Nerve grafting. J Bone Joint Surg 45B: 447-461, 
1963. 
93. Seddon HJ, Holmes W: The late condition of nerve homografts 
in man. Surg Gynec Obstet 79: 342-351, 1944. 
94. Singh R: Experience with allografts in the surgery of 
peripheral nerves. Acta Neurochir 34: 195-201, 1976. 
95. Singh R, Mechelse K, Stefanko S: Role of tissue typing on 
preserved nerve allografts in dogs. J Neurol Neurosurg 
Psychiatry 40: 865-871, 1977. 
96. Singh R, Vriesendorp HM, Mechelse K, Stefanko S: Cadaver 
nerve allografts in dogs. Biomedicine. 35: 67-70, 1981. 
97. Singh R, Vriesendorp HM, Mechlelse K, Stafanko S: Nerve 
allografts and histocompatibility in dogs. J Neurosurg 47: 
737-743, 1977. 
98. Snyder CC: Epineural repair orthop clinics north. Am 12: 
267-276, 1981. 

Ruwe 120 
99. Spurling PG, Lyons WR, Whitcomb BB, Woodhall B: The failure 
of whole fresh homogenous nerve grafts in man. J Neurosurg 
2: 79-101, 1945. 
100. Stearns MP: The effects of irradiation on nerve grafting. 
Clin Otolaryngol 7: 161-164, 1982. 
101. Stolov WC, Weilepp TG, Riddell WM: Passive length-tension 
relationship and hydroxyproline content of chronically 
denervated skeletal muscle. Arch Phys Med Rehabic 51: 
517-25, 1970. 
102. Stooky B: Surgical and mechanical treatment of peripheral 
nerve. Saunders Philadelphia, 1922. 
103. Stromberg BU, Vlaston C, Earle AS: Effect of nerve graft 
polarity on nerve regeneration and function. J Hand Surg 4: 
444-445, 1979. 
104. Sunderland S: The anatomic foundation of peripheral nerve 
repair techniques. Orth Clinics North Am 12: 245-266, 1981. 
105. Tenzis JK, Dykes RW, Hakstian PW: Electrophysiological 
recordings in peripheral nerve surgery: a review. J Hand 
Surgery 1: 52-66, 1976. 
106. Tomford WW: Cryopreservation of articular cartilage. 
Banking Methodology: 215-217. 

Ruwe 121 
107. Tomford WW, Duff GP, Mankin HJ: Experimental 
freeze-preservation of chonocytes. Clin Orthop 197: 11-14, 
1985. 
108. Verga G: Results of operations on peripheral nerves. 
Inter-allied conference. After-care disabled men 2: 
441-443, 1918. 
109. Verhoog BD, Van Bekkum DW: Peripheral nerve allografts: 
modifications of allograft reaction using experimental model 
in rats. Transplantation Proc 3: 591-593, 1971. 
110. Voiko M: Allotransplantation of joints. J Bone Joint Surg 
52 B: 49, 1970. 
111. Wilgis EFS, Maxwell GP: Distal digital nerve grafts: 
clinical and anatomical studies. J Hand Surg 4: 439-43, 
1979. 
112. Woessner JF: The determination of hydroxyproline in tissue 
and protein samples containing small proportions of this 
amino acid. Arch Biochem Biophys 93: 440-447, 1964. 
113. Woessner JF Jr: Determination of hydroxyproline in 
connective tissues. Methodology of Connective Tissue 
Research. Chap. 23, 1976. 

Ruwe 122 
114. Wood PM: Separation of functional Schwann cells and neurons 
from normal peripheral nerve tissue. Brain Res 115: 
361-375, 1976. 
115. Zalewski AA, Gulati AK: Rejection of nerve allografts after 
cessation of immunosuppression with cyclosporin. 
Transplantation 1: 88-89, 1981. 
116. Zalewski AA, Gulati AK: Survival of nerve and Schwann cells 
in allografts after cyclosporin-A treatment. Exp Neurology 
70: 219-225, 1980. 
117. Zalewski AA, Gulati AK: Loss of host axons in nerve 
allografts after abolishing immunological tolerance in 
rats. Exp Neurology 72: 502-506, 1981. 
118. Zalewski AA, Gulati AK: Evaluation of histocompatibility as 
a factor in the repair of nerve with a frozen nerve 
allograft. J Neurosurg 56: 550-554, 1982. 
119. Zalewski AA, Gulati AK: Failure of cyclosporin-A to induce 
immunological unresponsiveness to nerve allografts. Exp 
Neurology 83: 659-663, 1984. 
120. Zalewski AA, Gulati AK: Survival of nerve allografts in 
sensitized rats treated with cyclosporin-A. J Neurosurg 60: 
828-834, 1984. 

Ruwe 123 
121. Zalewski AA, Silvers WK: An evaluation of nerve repair with 
nerve allografts in normal and immunologically tolerant 
rats. J Neurosurg 52: 557-563, 1980. 
122. Zalewski AA, Silvers WK, Gulati AK: Failure of host axons 
to regenerate through a once successful but later rejected 
long nerve allograft. J Comp Neurology 209: 347-351, 1982. 
123. Mackinnon SE, Hudson AR, Hunter DA: Histological assessment 
of nerve regeneration in the rat. Plast Reconstr Surg 75: 
384-88, 1985. 
124. Marmor L: Peripheral Nerve Regeneration Using Nerve 
Grafts. Charles C. Thomas, Springfield, IL 1967. 
125. Discussion with Dr. Charles Greer. Department of Neuro 
anatomy, Yale University School of Medicine. 
126. Bassett CA, Campbell JB, Husby J: Peripheral nerve and 
spinal cord regeneration. Factors leading to the success of 
a tubulation technique employing millipore. Exper Neurol 1: 
386-406, 1959. 
127. Florio L, Stewart M, Mugrage ER: The effect of freezing on 
erythrocytes. J Lab Clin Med 28: 1486-90, 1943. 

Ruwe 124 
128 Keith SC: Factors influencing the survival of bacteria at 
low temperattures in the vicinity of the freezing point of 
water. Science 37: 877-79, 1913. 
129. Lovelock JE, Bishop MWH: Prevention of freezing damage to 
living cells by Dimethyl Sulfoxide. Nature 183: 1394-95, 
1959. 
130. Luyet BJ, Hodapp EL: Revival of frog spermatazoa vitrified 
in liquid air. Proc Soc Biol Med 39: 433-35, 1938. 
131. Polge C, Smith AU, Parkes AS: Revival of spermatazoa after 
vitrification and dehydration at low temperature. Natture 
164: 666, 1949. 


\ 



; MEDICAL LIBRARY 
3 9002 0101 1 9148 
YALE MEDICAL LIBRARY 
YALE MEDICAL LIBRARY 
Manuscript Theses 
Unpublished theses submitted for the Master's and Doctor's degrees and 
deposited in the Yale Medical Library are to be used only with due regard to the 
rights of the authors. Bibliographical references may be noted, but passages 
must not be copied without permission of the authors, and without proper credit 
being given in subsequent written or published work. 
This thesis by has been 
used by the following persons, whose signatures attest their acceptance of the 
above restrictions. 
NAME AND ADDRESS DATE 

